OID,ValueSetName,ExpansionVersion,CodeSystemName,CodeSystemVersion,CodeSystemOID,Purpose
2.16.840.1.113883.3.526.3.1139,ACE Inhibitor or ARB,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB) therapies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs concepts associated with component, form and strength); generic; prescribable; ACE inhibitor, ARB therapy, combination drugs such as ACEI plus diuretic, ARB plus neprilysin inhibitor (ARNI), ARB plus diuretic, ACEI plus calcium channel blocker, ARB plus calcium channel blocker, or ARB plus calcium channel blocker plus diuretic.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)"
2.16.840.1.113883.3.526.3.1489,ACE Inhibitor or ARB Ingredient,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB) ingredients.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Allergy/Intolerance.),(Inclusion Criteria: Includes only relevant concepts associated with prescribable angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB) ingredients only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1171,ADHD Medications,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent attention deficit hyperactivity disorder (ADHD) medications. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active and Medication, Dispensed.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; ADHD medications only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1525,Above Normal Follow-up,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent interventions relevant for a follow up for a BMI above normal measurement.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with interventions relevant for a follow up when BMI is above normal measurement.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1498,Above Normal Medications,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent clinical medications prescribed for weight loss to patients with an above normal BMI measurement.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. ),(Inclusion Criteria: Includes only relevant concepts associated with oral drug forms prescribed for weight loss in patients with an above normal BMI measurement.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1317,Acetaminophen / Butalbital,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / butalbital combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / butalbital (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / butalbital in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1363,Acetaminophen / Butalbital / Caffeine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / butalbital / caffeine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / butalbital / caffeine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / butalbital / caffeine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1326,Acetaminophen / Butalbital / Caffeine / Codeine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / butalbital / caffeine / codeine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / butalbital / caffeine / codeine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / butalbital / caffeine / codeine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1421,Acetaminophen / Chlorpheniramine / Dextromethorphan,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / dextromethorphan combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / dextromethorphan (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / dextromethorphan in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1310,Acetaminophen / Chlorpheniramine / Dextromethorphan / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1321,Acetaminophen / Chlorpheniramine / Dextromethorphan / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1328,Acetaminophen / Chlorpheniramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1316,Acetaminophen / Chlorpheniramine / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1405,Acetaminophen / Dexbrompheniramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / dexbrompheniramine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dexbrompheniramine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dexbrompheniramine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1399,Acetaminophen / Dextromethorphan / Diphenhydramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / dextromethorphan / diphenhydramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dextromethorphan / diphenhydramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dextromethorphan / diphenhydramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1338,Acetaminophen / Dextromethorphan / Doxylamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / dextromethorphan / doxylamine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dextromethorphan / doxylamine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dextromethorphan / doxylamine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1287,Acetaminophen / Dextromethorphan / Doxylamine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / dextromethorphan / doxylamine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dextromethorphan / doxylamine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dextromethorphan / doxylamine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1350,Acetaminophen / Diphenhydramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / diphenhydramine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / diphenhydramine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / diphenhydramine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1318,Acetaminophen / Diphenhydramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent acetaminophen / diphenhydramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / diphenhydramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / diphenhydramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.117.1.7.1.377,Activation of Emergency Medical System Education,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to represent patients who receive emergency medical system education.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication. The intent of this data element is to identify patients who receive education on the activation of emergency medical system. ),(Inclusion Criteria: Includes only relevant concepts associated with only SNOMED CT codes representing emergency medical system education.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.104.12.1001,Acute Myocardial Infarction,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of acute myocardial infarction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with all patients who have had an acute myocardial infarction.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.102.12.1011,Acute Pharyngitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses of bacterial or viral acute pharyngitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of either bacterial and viral acute pharyngitis. This is a value set grouping that includes ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.102.12.1012,Acute Tonsillitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses of bacterial or viral acute tonsillitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes relevant concepts associated with a diagnosis of either bacterial and viral acute tonsillitis. This is a value set grouping that includes ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1241,Acute and Subacute Iridocyclitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of acute and subacute iridocyclitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of acute and subacute iridocyclitis, including primary and secondary iridocyclitis, and hypopyon.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.666.5.3022,Acute or Evolving MI,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses used to identify patients with an acute or evolving myocardial infarction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Result. The intent of this data element is to identify patients with an acute or evolving myocardial infarction. ),(Inclusion Criteria: Includes only relevant concepts associated with codes that identify patients with an acute or evolving myocardial infarction. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1542,Additional evaluation for depression - adolescent,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent interventions and procedures where an adolescent patient received additional evaluation to determine the presence of depression.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with psychiatric interview and evaluations used to determine the presence of depression, bipolar, or other mental health diagnoses.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1545,Additional evaluation for depression - adult,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent interventions and procedures where an adult patient received additional evaluation to determine the presence of depression.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with psychiatric interview and evaluation for testamentary capacity, rehabilitation, criminal responsibility, bipolar disorder and mental status.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1405,Adhesions and Disruptions of Iris and Ciliary Body,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of adhesions and disruptions of the iris and ciliary body.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of synechiae, iridodialysis, pupillary membranes or abnormalities, and other syndromes of the iris or ciliary body.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.' )"
2.16.840.1.113883.3.464.1003.101.12.1065,Adult Outpatient Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent office or other outpatient visits, including home visits.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.106.12.1001,Alcohol and Drug Dependence,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent alcohol and drug dependence.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with alcohol and drug abuse and dependence. This is a grouping of ICD-10CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes related to alcohol and drug use.)"
2.16.840.1.113883.3.464.1003.106.12.1005,Alcohol and Drug Dependence Treatment,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent treatment for alcohol and drug dependence.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with assessment, management, and both psychosocial and pharmacological treatment of alcohol and drug dependence. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1211,Allergy to ACE Inhibitor or ARB,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of allergy to angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of allergy to ACE inhibitor or ARB.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1177,Allergy to Beta Blocker Therapy,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of allergy to beta blocker therapy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of allergy to beta blocker therapy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1253,Allergy to Eggs,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of an allergy to eggs.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of allergy to eggs.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1256,Allergy to Influenza Vaccine,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of an allergy to influenza vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of allergy to influenza vaccines.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1448,Amblyopia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of amblyopia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of amblyopia, including suspected amblyopia.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.' )"
2.16.840.1.113883.3.464.1003.122.12.1003,Ambulatory,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent encounters in an ambulatory setting.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with care in an ambulatory setting.),(Exclusion Criteria: Excludes patients who had ambulatory hospice care.)"
2.16.840.1.113883.3.464.1003.118.11.1219,Ambulatory Status,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent assessment of gait or balance to identify risk factors for falls.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all gait and balance assessment tools such as the Morse Fall Scale and the Parkinson's Unified Parkinson’s Disease Rating Scale. This is an extensional value set of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.687,Ambulatory surgical center,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent an environment type used to identify an ambulatory surgical center.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category Encounter or attribute Admission Source. The intent of this data element is to identify an environment type that defines an ambulatory surgical center. ),(Inclusion Criteria: Includes only relevant concepts associated with ambulatory surgical centers.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1061,Ambulatory/ED Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an interaction with a member of their medical care team in the emergency department or an ambulatory care setting.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with care provided to new and established patients in the emergency department or ambulatory care setting. Includes only relevant concepts associated with ED, home health, in-office, and observation visits. This is a value set grouping that contains CPT and SNOMED CT codes.),(Exclusion Criteria: Excludes encounters that occurred in the inpatient setting.)"
2.16.840.1.113883.3.464.1003.196.12.1286,Amitriptyline  /  Chlordiazepoxide,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent amitriptyline / chlordiazepoxide combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amitriptyline / chlordiazepoxide (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amitriptyline / chlordiazepoxide in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1428,Amitriptyline / Perphenazine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent amitriptyline / perphenazine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amitriptyline / perphenazine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amitriptyline / perphenazine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1373,Amitriptyline Hydrochloride,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent amitriptyline hydrochloride medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amitriptyline hydrochloride only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amitriptyline hydrochloride in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1273,Amoxapine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent amoxapine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amoxapine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amoxapine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.199.12.1032,Anaphylactic Reaction to Common Baker's Yeast,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a history of an anaphylactic (extreme allergy) reaction to baker's yeast.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with an anaphylactic reaction to baker's yeast.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.199.12.1031,Anaphylactic Reaction to DTaP Vaccine,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a history of an anaphylactic (extreme allergy) reaction to DTaP (diphtheria, tetanus, and acellular pertussis) vaccine.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with an anaphylactic reaction to DTaP vaccine.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.199.12.1026,Anaphylactic Reaction to Hepatitis A Vaccine,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a history of an anaphylactic (extreme allergy) reaction to hepatitis A vaccine.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with an anaphylactic reaction to hepatitis A vaccine.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1151.48,Androgen deprivation therapy for Urology Care,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent androgen deprivation therapy as identified for urology care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. This data element is to list androgen deprivation therapy for urology care for prostate cancer.),(Inclusion Criteria: Includes only relevant concepts associated with androgen deprivation therapy medications.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1045,Ankylosing Spondylitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of ankylosing spondylitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with ankylosing spondylitis with comorbidities and associated system involvement. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes all diagnosis codes associated with juvenile ankylosing spondylitis.)"
2.16.840.1.113883.3.526.2.1363,Annual Wellness Visit,eCQM Update 2018-09-17,HCPCS,2018,2.16.840.1.113883.6.285,"(Clinical Focus: This value set contains concepts that represent annual wellness visits.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have had an annual wellness visit. ),(Inclusion Criteria: Includes only relevant concepts associated with encounters specific to annual wellness visits.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1240,Annual Wellness Visit,eCQM Update 2018-09-17,HCPCS,2018,2.16.840.1.113883.6.285,"(Clinical Focus: This value set grouping contains concepts that represent annual wellness visits.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have had an annual wellness visit. ),(Inclusion Criteria: Includes only relevant concepts associated with encounters specific to annual wellness visits.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1406,Anomalies of Pupillary Function,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of pupillary function anomalies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of miosis and constricted pupil.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.198.12.1033,Anti Hepatitis A IgG Antigen Test,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests to detect anti hepatitis A immunoglobulin (IgG) antibodies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test),(Inclusion Criteria: Includes only relevant concepts associated with test codes for IgG antibody to hepatitis A.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1073,Anti Hepatitis B Virus Surface Ab,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests to detect anti hepatitis B surface antigen in the blood.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with test codes for anti-surface antibody in the blood related to hepatitis B virus. This sounds weird. Please re-read.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1481,"Anti Infectives, other",eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent nitrofurantion (anti-infective medications).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (component, form and strength); generic; human only; prescribable; nitrofurantion medications.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; nitrofurantion in combination with other medications.)"
2.16.840.1.113883.3.600.1476,Anti-Hypertensive Pharmacologic Therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent clinical medications prescribed for patients diagnosed with hypertension.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with oral and injectable drug forms that are prescribed for treatment of hypertension.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1001,Antibiotic Medications for Pharyngitis,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent antibiotic medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; antibiotics only.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; antibiotics in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1283,Anticoagulant Medications,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent anticoagulant medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; anticoagulant medications only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.200,Anticoagulant Therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medications that are prescribed for anticoagulant therapy at hospital discharge for patients following acute ischemic stroke.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed anticoagulant therapy at discharge following acute ischemic stroke. ),(Inclusion Criteria: Includes only relevant concepts associated with oral and injectable drug forms. Includes only relevant concepts associated with warfarin, heparins and direct thrombin inhibitors.),(Exclusion Criteria: Excludes codes for enoxaparin and heparin generally given for VTE prophylaxis.)"
2.16.840.1.113883.3.464.1003.196.12.1213,Antidepressant Medication,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent antidepressant medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Dispensed.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable. Includes only relevant concepts associated with antidepressant medication. This is a grouping of RxNorm codes.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)"
2.16.840.1.113883.3.117.1.7.1.201,Antithrombotic Therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent anticoagulant and antiplatelet medications used to reduce stroke mortality and morbidity.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive antithrombotic therapy following stroke. ),(Inclusion Criteria: Includes only relevant concepts associated with single and multi-ingredient drugs. Oral, rectal, and injectable dose forms should be included. Antithrombotic medications includes only relevant concepts associated with anticoagulants and antiplatelet drugs.),(Exclusion Criteria: Excludes codes for enoxaparin and heparin generally given for VTE prophylaxis.)"
2.16.840.1.113883.3.666.5.1151,Aortic balloon pump insertion,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to identify aortic balloon pump insertion.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed. The intent of this data element is to identify patients with the procedure aortic balloon pump insertion. ),(Inclusion Criteria: Includes only relevant concepts associated with codes that describe insertion of the aortic balloon pump.),(Exclusion Criteria: Excludes codes that describe complications and procedures for removing the device.)"
2.16.840.1.113883.3.526.3.1407,Aphakia and Other Disorders of Lens,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of disorders of lens, including aphakia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of dislocation or subluxation of lens.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.196.12.1265,Aromatase Inhibitors,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent aromatase inhibitor medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; both steroidal and non-steroidal inhibitors; both non-selective and selective inhibitors; aromatase inhibitors only.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; aromatase inhibitors in combination with other medications; selective inhibitors vorozole, formestane, and fadrozole.)"
2.16.840.1.113883.3.526.3.366,Arrhythmia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of arrhythmia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria:  Includes only relevant concepts associated with a diagnosis of arrhythmia.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1045.57,Artificial Rupture of Membranes,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures that represent the artificial rupture of membranes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify artificial rupture of membranes as a mechanism to induce labor. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify artificial rupture of membranes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1408,Aspiration and Injection Procedures,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent aspiration and injection procedures of the eye.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with injections in the anterior chamber of the eye.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1347,Aspirin / Butalbital / Caffeine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent aspirin / butalbital / caffeine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; aspirin / butalbital / caffeine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; aspirin / butalbital / caffeine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1302,Aspirin / Caffeine / Orphenadrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent aspirin / caffeine / orphenadrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; aspirin / caffeine / orphenadrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; aspirin / caffeine / orphenadrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1211,Aspirin and Other Antiplatelets,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent aspirin and other antiplatelet medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; aspirin and other antiplatelets medications only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.362,Asthma,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnosis of asthma.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of asthma.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.271,Asthma,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis indicative of asthma.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have a diagnosis of asthma. ),(Inclusion Criteria: Includes only relevant concepts associated with codes representing any form of asthma. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.21,Atherosclerosis and Peripheral Arterial Disease,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis, condition, or disorder of atherosclerosis or peripheral arterial disease (PAD).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with conditions that indicate arterial blood flow is restricted putting patients at higher risk for heart disease.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.203,Atrial Ablation,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent atrial ablation procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients with a history of atrial ablation procedure.),(Inclusion Criteria: Includes only relevant concepts associated with codes that identify patients with a history of atrial ablation procedure. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113883.3.117.1.7.1.202,Atrial Fibrillation/Flutter,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set grouping contains concepts that represent diagnoses used to identify patients with a history of atrial fibrillation/flutter or a current finding of atrial fibrillation/flutter.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis. The intent of this data element is to identify patients with a diagnosis of atrial fibrillation or flutter. ),(Inclusion Criteria: Includes only relevant concepts associated with codes that identify patients with a history of atrial fibrillation/flutter or a current finding of atrial fibrillation/flutter. This is a grouping of ICD-10-CM, ICD-9-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.367,Atrioventricular Block,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of atrioventricular block.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of atrioventricular block.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1274,Atropine / Diphenoxylate,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent atropine / diphenoxylate combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; atropine / diphenoxylate (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; atropine / diphenoxylate in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1355,Atropine / Hyoscyamine / Phenobarbital / Scopolamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent atropine / hyoscyamine / phenobarbital / scopolamine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; atropine / hyoscyamine / phenobarbital / scopolamine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; atropine / hyoscyamine / phenobarbital / scopolamine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.101.12.1066,Audiology Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent assessment tools or instruments used to quantify hearing.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with hearing assessment tools and instruments used to quantify hearing such as basic vestibular evaluation, spontaneous and positional nystagmus testing, and computerized dynamic posturography. This is a grouping of CPT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.106.12.1018,Average Number of Drinks per Drinking Day,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent a patient's number of alcoholic drinks per drinking day.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying a quantitative observation of the reported number of alcoholic drinks per drinking day. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.1257.1.972,BH Antidepressant Medication,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.1257.1.1604,BH Assessment for Alcohol or Other Drugs,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.1257.1.1504,BH Condition Involving Bipolar Disorder,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.1257.1.1505,BH Condition Involving Unipolar Depression,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.1257.1.1616,BH Counseling for Depression,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.1257.1.1533,BH Electroconvulsive Therapy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.1257.1.950,BH Mood Stabilizer Medication,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.1257.1.973,BH Outpatient Psychotherapy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.464.1.49,BH Outpatient encounter,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: Under development),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: 0),(Exclusion Criteria: 0)"
2.16.840.1.113883.3.600.1.1751,BMI Encounter Code Set,eCQM Update 2018-09-17,CDT,2018,2.16.840.1.113883.6.13,"(Clinical Focus: This value set contains concepts that represent multiple types of encounters for body mass index (BMI) assessment.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with multiple types of encounters that enable BMI measurement.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1490,BMI Ratio,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent a body mass index (BMI) ratio.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with or related to BMI ratio.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.121.12.1012,BMI percentile,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent BMI percentile. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Physical Exam, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying BMI percentile as a result. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1920,BP Screening Encounter Codes,eCQM Update 2018-09-17,CDT,2018,2.16.840.1.113883.6.13,"(Clinical Focus: This value set contains concepts that represent multiple types of encounters where blood pressure measurement screening can be performed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with encounters where the actual procedure of taking a blood pressure is performed.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1054,Behavioral Health Follow-up Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had a behavioral health follow-up visit.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with health and behavior assessment or intervention, or education and training for patient self-management by a physician or other qualified health care professional.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1023,Behavioral/Neuropsych Assessment,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits for assessments for neuropsychological assessments.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with applicable neuropsychological assessments for behavioral health.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1528,Below Normal Follow up,eCQM Update 2018-09-17,HCPCS,2018,2.16.840.1.113883.6.285,"(Clinical Focus: This value set contains concepts that represent a follow up with a BMI below normal measurement.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with a follow up when BMI is below normal measurement.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1499,Below Normal Medications,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent clinical medications prescribed for weight gain to patients with a below normal BMI measurement.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with oral drug forms prescribed for weight gain in patients with a below normal BMI measurement.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1361,Benztropine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent benztropine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; benztropine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; benztropine in combination with other medications.)"
2.16.840.1.113883.3.526.3.1174,Beta Blocker Therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent beta blocker therapy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; penbutolol sulfate, betaxolol hydrochloride, propranolol hydrochloride, atenolol/chlorthalidone, sotalol hydrochloride, metoprolol tartrate, nebivolol/valsartan, atenolol, bendroflumethiazide, nadolol, pindolol, timolol, oxprenolol, clopamide/pindolol, carvedilol, hydrochlorothiazide/pindolol, nebivolol, bisoprolol, bisoprolol/hydrochlorothiazide, hydrochlorothiazide/propranolol hydrochloride, propranolol hydrochloride, metoprolol, hydrochlorothiazide/metoprolol succinate, hydrochlorothiazide/metoprolol tartrate, labetalol, sotalol, acebutolol.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)"
2.16.840.1.113883.3.526.3.1493,Beta Blocker Therapy Ingredient,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent beta blocker therapy ingredients.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Allergy/Intolerance.),(Inclusion Criteria: Includes only relevant concepts associated with prescribable ingredient only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1184,Beta Blocker Therapy for LVSD,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent beta blocker therapy for left ventricular systolic dysfunction (LVSD).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; bisoprolol, carvedilol, or sustained release metoprolol succinate.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)"
2.16.840.1.113883.3.464.1003.198.12.1005,Bilateral Mastectomy,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent bilateral mastectomy procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with a bilateral mastectomy. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: Excludes codes that indicate a unilateral mastectomy or are unspecified.)"
2.16.840.1.113883.3.464.1003.113.12.1056,Bilateral amputation of leg below or above knee,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of bilateral amputation of the leg below or above the knee.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying all patients who have had a bilateral amputation of the leg below or above the knee.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.450,Bipolar Diagnosis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses of bipolar disorder.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with mild to severe cases, brief episodes, or chronic disorders, which would indicate that there is a current diagnosis of bipolar disorder documented by the healthcare provider.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.67.1.101.1.128,Bipolar Disorder,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses related to bipolar disorder.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant diagnoses associated with bipolar disorder. This is a grouping of SNOMED CT, ICD-9-CM, and ICD-10-CM codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1056,Blood Pressure Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent encounters in which blood pressure was assessed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with office visit, face to face interaction, preventive care services, home healthcare services, and annual wellness care.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.320,Bone Scan,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent bone scan diagnostic imaging.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study.),(Inclusion Criteria: Includes only relevant concepts associated with conventional technetium-99m-MDP bone scan as well as 18F-NaF PET (or PET/CT) scan.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.412,Bradycardia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of bradycardia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of bradycardia.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.30,Breast Milk,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent breast milk.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Substance. The intent of this data element is to identify breast milk.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify breast milk.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.73,Breastfeeding,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent active breastfeeding.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with lactation and the actual finding or intention of breastfeeding or nursing.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1427,Brompheniramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent brompheniramine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; brompheniramine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1409,Brompheniramine / Codeine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent brompheniramine / codeine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / codeine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / codeine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1450,Brompheniramine / Codeine / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent brompheniramine / codeine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / codeine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / codeine / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1325,Brompheniramine / Dextromethorphan / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent brompheniramine / dextromethorphan / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / codeine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / codeine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1339,Brompheniramine / Dextromethorphan / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent brompheniramine / dextromethorphan / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / dextromethorphan / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / dextromethorphan / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1327,Brompheniramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent brompheniramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1332,Brompheniramine / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent brompheniramine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.526.3.1409,Burn Confined to Eye and Adnexa,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of a burn of the eye and/or adnexa.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of burn of various parts of the eye, or eye corrosion.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.196.12.1402,Butabarbital,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent butabarbital medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; butabarbital only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; butabarbital in combination with other medications.)"
2.16.840.1.113883.3.666.5.694,CABG Surgeries,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent coronary artery bypass (CABG) surgical procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have a CABG surgical procedure.),(Inclusion Criteria: Includes only relevant concepts associated with CABG surgical procedures. This is a grouping of SNOMED CT, ICD-9-CM, and ICD-10-CM codes.),(Exclusion Criteria: Excludes codes that represent a CABG performed using a scope.)"
2.16.840.1.113883.3.464.1003.121.12.1004,CD4+ Count,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent CD4+ count laboratory tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with codes that identify CD4+ counts with a count/vol observation or CD3+CD4+ (T4 helper) cells [#/volume]. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.121.12.1005,CD4+ Percentage,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the CD4+ percentage laboratory tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with codes that identify CD4+ percentages with CD3+CD4+ (T4 helper) in the code name. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.108.12.1038,CT Colonography,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent identify a computed tomographic (CT) colonography.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with patients that have had a CT colonography. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1010,Cancer,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a cancer diagnosis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with cancer diagnoses.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1536,Cancer Staging,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent cancer staging with the intent to obtain information such as the tumor size.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with cancer staging.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1306,Carbinoxamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent carbinoxamine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; carbinoxamine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; carbinoxamine in combination with other medications.)"
2.16.840.1.113883.3.526.3.1193,Cardiac Pacer,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a cardiac pacer device.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Device.),(Inclusion Criteria: Includes only relevant concepts associated with a cardiac pacer device.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.368,Cardiac Pacer in Situ,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of cardiac pacer in situ.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of cardiac pacer in situ.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.371,Cardiac Surgery,eCQM Update 2018-09-17,CPT,2012,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent cardiac surgery.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with cardiac surgery.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.748,Cardiopulmonary arrest,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent patients with a cardiopulmonary arrest.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Principal Diagnosis. The intent of this data element is to identify patients with a diagnosis of cardiopulmonary arrest.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes that identify cardiac arrest.),(Exclusion Criteria: Excludes codes that describe history of cardiac arrest.)"
2.16.840.1.113883.3.464.1003.101.12.1014,Care Services in Long-Term Residential Facility,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients living in assisted living, domiciliary care or rest homes who have had an interaction with a member of their medical team.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with services provided to new and established patients living in assisted living, domiciliary care or rest home. This is a grouping value set of CPT codes.),(Exclusion Criteria: Excludes visits in settings other than assisted living, domiciliary care or rest homes.)"
2.16.840.1.113883.3.464.1003.196.12.1369,Carisoprodol,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent carisoprodol medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; carisoprodol only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; carisoprodol in combination with other medications.)"
2.16.840.1.113883.3.117.1.7.1.204,Carotid Intervention,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent carotid intervention surgical procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with representing carotid intervention surgical procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.112.11.1023,Carrier of Predominantly Sexually Transmitted Infection,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent exposure to infections that are primarily transmitted through sexual contact.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with potential exposure to infection with a predominantly sexual mode of transmission.),(Exclusion Criteria: Excludes codes for specific sexually transmitted infections.)"
2.16.840.1.113883.3.526.3.1410,Cataract Secondary to Ocular Disorders,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of cataract that is a secondary diagnosis to other ocular conditions.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of cataract secondary to degenerative or inflammatory ocular disorders, cataract with neovascularization, or subcapsular glaucomatous flecks.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1411,Cataract Surgery,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent cataract surgical procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with cataract surgery.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1412,"Cataract, Congenital",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of congenital cataract.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of congenital cataract.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1413,"Cataract, Mature or Hypermature",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of mature or hypermature cataract.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of mature or hypermature cataract, including senile or intumescent cataract.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1414,"Cataract, Posterior Polar",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of posterior polar cataract.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of posterior polar cataract, including capsular or subcapsular cataract.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1428,Central Corneal Ulcer,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of central corneal ulcer.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of central corneal ulcer or keratitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113762.1.4.1047.44,"Cerebrovascular disease, Stroke, TIA",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent stroke and high risk diagnoses associated with stroke, including transient ischemic attack (TIA) and generalized ischemic cerebrovascular disease, which would indicate a patient has atherosclerotic cardiovascular disease (ASCVD) in relation to a cerebrovascular event. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with ASCVD diagnoses of cerebrovascular origin.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1415,Certain Types of Iridocyclitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of various types of iridocyclitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of lens-induced iridocyclitis, Fuchs' heterochromic cyclitis, Vogt-Koyanagi syndrome, and other types of iridocyclitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.117.1.7.1.282,Cesarean Birth,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent cesarean sections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify cesarean section.),(Inclusion Criteria: Includes only relevant concepts associated with ICD-9-CM, ICD-10-CM and SNOMED CT codes that identify cesarean section.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1027,Chemotherapy Administration,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent chemotherapy administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with chemotherapy administration.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.112.12.1003,Chlamydia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent chlamydia infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with all relevant concepts associated with chlamydia infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1052,Chlamydia Screening,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory testing for chlamydia infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with tests for chlamydia infection. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1412,Chlophedianol / Chlorpheniramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlophedianol / chlorpheniramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlophedianol / chlorpheniramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlophedianol / chlorpheniramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1447,Chlophedianol / Dexchlorpheniramine / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlophedianol / dexchlorpheniramine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlophedianol / dexchlorpheniramine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlophedianol / dexchlorpheniramine / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1352,Chlorpheniramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1301,Chlorpheniramine / Codeine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / codeine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / codeine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / codeine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1312,Chlorpheniramine / Dextromethorphan / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / dextromethorphan / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / dextromethorphan / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / dextromethorphan / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1337,Chlorpheniramine / Dextromethorphan / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / dextromethorphan / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / dextromethorphan / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / dextromethorphan / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1330,Chlorpheniramine / Hydrocodone,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / hydrocodone combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / hydrocodone (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / hydrocodone in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1299,Chlorpheniramine / Hydrocodone / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / hydrocodone / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / hydrocodone / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / hydrocodone / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1343,Chlorpheniramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1453,Chlorpheniramine / Phenylephrine / Phenyltoloxamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / phenylephrine / phenyltoloxamine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / phenylephrine / phenyltoloxamine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / phenylephrine / phenyltoloxamine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1309,Chlorpheniramine / Phenylephrine / Pyrilamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / phenylephrine / pyrilamine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / phenylephrine / pyrilamine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / phenylephrine / pyrilamine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1315,Chlorpheniramine / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpheniramine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1303,Chlorpropamide,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorpropamide medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpropamide only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpropamide in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1362,Chlorzoxazone,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent chlorzoxazone medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorzoxazone only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorzoxazone in combination with other medications.)"
2.16.840.1.113883.3.526.3.1449,Chorioretinal Scars,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of chorioretinal scars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of chorioretinal scarring, including the choroid and retina.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1450,Choroidal Degenerations,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of choroidal degenerations.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of degenerations of the choroid, including choroid atrophy and dystrophy, angioid streaks, and choroideremia.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1451,Choroidal Detachment,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of choroidal detachment.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis choroidal detachment, or effusion.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1452,Choroidal Hemorrhage and Rupture,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of choroidal hemorrhage and/or rupture.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with choroidal hemorrhage and rupture.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1416,Chronic Iridocyclitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of chronic iridocyclitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of chronic or recurrent iridocyclitis or tuberculous iridocyclitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1002,"Chronic Kidney Disease, Stage 5",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of Stage 5 chronic kidney disease.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with Stage 5 of chronic kidney disease.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.199.12.1035,Chronic Liver Disease,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of chronic liver disease.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for chronic liver disease or cirrhosis, liver abscess or sequelae of chronic liver disease and other disorders of the liver. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.199.12.1036,Chronic Malnutrition,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of chronic malnutrition.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for specified and unspecified eating disorders. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes all diagnosis codes for feeding disorders of infancy or childhood. These include feeding disturbances, developmental delays, loss of appetite and rumination. Also excludes restrictive food intake disorders and pica.)"
2.16.840.1.113883.3.117.1.7.1.421,Classical Cesarean Birth,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent cesarean sections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify classical cesarean section.),(Inclusion Criteria: Includes only relevant concepts associated with ICD-10-PCS and SNOMED CT codes that identify the classical cesarean section.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1308,Clemastine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent clemastine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; clemastine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; clemastine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.125.12.1003,Clinical Oral Evaluation,eCQM Update 2018-09-17,CDT,2018,2.16.840.1.113883.6.13,"(Clinical Focus: This value set contains concepts that represent patients who had a clinical oral evaluation.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with periodic, limited (problem focused), comprehensive oral evaluations and re-evaluations.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1336,Clomipramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent clomipramine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; clomipramine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; clomipramine in combination with other medications.)"
2.16.840.1.113883.3.526.3.1417,Cloudy Cornea,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of cloudy cornea.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of opacity of the cornea, adherent or corneal leukoma, and haziness of the cornea.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1332,Cognitive Assessment,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent assessments performed for the evaluation of cognition.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with general concepts for assessments used to evaluate cognition.),(Exclusion Criteria: Excludes standardized tools used to evaluate cognition.)"
2.16.840.1.113883.3.464.1003.108.12.1020,Colonoscopy,eCQM Update 2018-09-17,CPT,2014,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent colonoscopy procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts that identify patients who have had a screening or diagnostic colonoscopy. This is a grouping of CPT, HCPCS, and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
1.3.6.1.4.1.33895.1.3.0.45,Comfort Measures,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent care regimes used to define comfort measure care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention. The intent of this data element is to identify patients receiving comfort measure care.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT regime and therapy codes for comfort measures, terminal care, dying care and hospice care.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.102.12.1017,Competing Conditions for Respiratory Conditions,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis for an acute bacterial infection that may warrant treatment with an antibiotic medication. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with the diagnosis of acute bacterial infections that may warrant treatment with an antibiotic medication. This is a value set grouping that includes ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes acute diagnoses that do not warrant treatment with an antibiotic medication.)"
2.16.840.1.113883.3.464.1003.111.12.1012,"Complications of Pregnancy, Childbirth and the Puerperium",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent complications related to pregnancy or childbirth.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with complications of pregnancy or childbirth. This is a grouping of ICD-10-CM, ICD-9-CM, and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1056.54,Conditions Due To Human Immunodeficiency Virus (HIV),eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses related to identifying human immunodeficiency virus (HIV).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses for patients with HIV. This is a grouping of SNOMED CT, ICD-9-CM, and ICD-10-CM codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.286,Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses for conditions justifying elective delivery prior to 39 weeks gestation.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. The intent of this data element is to identify conditions possibly justifying elective delivery prior to 39 weeks gestation.),(Inclusion Criteria: Includes only relevant concepts associated with ICD-10-CM and SNOMED CT codes that identify conditions possibly justifying elective delivery prior to 39 weeks gestation.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1357,Conjugated Estrogens,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent conjugated estrogen medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; conjugated estrogen medications.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; conjugated estrogens in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1324,Conjugated Estrogens / Medroxyprogesterone,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent conjugated estrogen / medroxyprogesterone combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; conjugated estrogens / medroxyprogesterone (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; conjugated estrogens / medroxyprogesterone in combination with other medications.)"
2.16.840.1.113883.3.464.1003.121.12.1006,Consultant Report,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent consultant reports.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication.),(Inclusion Criteria: Includes only relevant concepts associated with written consultant reports.),(Exclusion Criteria: Excludes reports that are conducted via telephone calls or verbal communication.)"
2.16.840.1.113762.1.4.1080.5,Contact or Office Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent contact and office visits for new and established patients, and includes in-person, telephone, online, and other visit types related to depression encounters.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with outpatient contact and office visits in which a patient may be evaluated for depression. This groups CPT and HCPCS codes. ),(Exclusion Criteria: Excludes inpatients for purposes of the index event. The majority of CPT codes are specified for outpatient visit types; however psychiatry and psychotherapy visits can be used in the inpatient setting. )"
2.16.840.1.113883.3.464.1003.196.12.1080,Contraceptive Medications,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent contraceptive medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Order.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable. Includes only relevant concepts associated with contraceptive medications. This is a grouping of RxNorm codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1418,Corneal Edema,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of corneal edema.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of corneal edema, including keratopathy.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1419,Corneal Opacity and Other Disorders of Cornea,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of corneal opacity and other corneal disorders.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of opacity of the cornea, adherent or corneal leukoma, scarring of the cornea, and corneal haze.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113762.1.4.1110.12,Cornual Ectopic Pregnancy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of cornual ectopic pregnancy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. The intent of this data element is to identify a cornual ectopic pregnancy.),(Inclusion Criteria: Includes only relevant concepts associated with codes representing cornual ectopic pregnancy.),(Exclusion Criteria: Excludes codes representing ectopic pregnancies other than cornual ectopic pregnancies, such as tubal ectopic pregnancies.)"
2.16.840.1.113883.3.464.1003.104.12.1002,Coronary Artery Bypass Graft,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent coronary artery bypass graft procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with patients who have had a coronary artery bypass graft procedure.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.369,Coronary Artery Disease No MI,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of coronary artery disease without myocardial infarction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of coronary artery disease without myocardial infarction.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.195.12.1003,Counseling for Nutrition,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent nutrition counseling.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with identifying counseling for nutrition, including codes for medical nutrition therapy, dietetics services, education about diet or different types of diets (e.g., low fat diet, high fiber diet), and weight loss management. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1035,Counseling for Physical Activity,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent physical activity counseling.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with identifying counseling or referrals related to physical activity, including codes related to weight management services.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1333,Cup to Disc Ratio,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent studies specific to obtaining cup to disc ratio by ophthalmoscopy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study.),(Inclusion Criteria: Includes only relevant concepts associated with studies using ophthalmoscopy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.2390,Current Tobacco Smoker,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the type and frequency of tobacco use.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype or attribute related to Diagnosis or Finding. ),(Inclusion Criteria: Includes only relevant concepts associated with type and frequency of tobacco user.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.117.12.1009,Cushings Syndrome,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of Cushing's syndrome.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis of Cushing's syndrome, including codes for drug-induced Cushing's syndrome, ectopic Adrenocorticotropic hormone  (ACTH) syndrome and unspecified Cushing's syndrome. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes. ),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1372,Cyclobenzaprine Hydrochloride,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent cyclobenzaprine hydrochloride medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; cyclobenzaprine hydrochloride only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; cyclobenzaprine hydrochloride in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1277,Cyproheptadine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent cyproheptadine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; cyproheptadine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; cyproheptadine in combination with other medications.)"
2.16.840.1.113883.3.526.3.1420,"Cysts of Iris, Ciliary Body, and Anterior Chamber",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of cysts of iris, ciliary body, and anterior chamber of the eye.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of cysts of iris, ciliary body, and anterior chamber.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113762.1.4.1151.38,"DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care",eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent bone density x-ray studies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study or Order. The intent of this data element is to identify patients with low bone mineral density. ),(Inclusion Criteria: Includes only relevant concepts associated with Dual-energy X-ray absorptiometry (DXA, DEXA) with 1 or more axial sites, axial skeleton (hips, pelvis, spine) or 1 or more appendicular skeleton sites (radius, wrist, heel). ),(Exclusion Criteria: No Exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1214,DTaP Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent diphtheria, tetanus, and whooping cough (pertussis) (DTaP) vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with diphtheria, tetanus, and whooping cough (pertussis) (DTaP) vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1022,DTaP Vaccine Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures for diphtheria, tetanus, and whooping cough (pertussis) (DTaP) vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with diphtheria, tetanus, and whooping cough (pertussis) (DTaP) vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1051,DXA (Dual energy Xray Absorptiometry) Scan,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent a dual-energy x-ray absorptiometry (DXA) scan.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study.),(Inclusion Criteria: Includes only relevant concepts associated with DXA scans of the femur, radius, ulna, lumbar spine, hip, calcaneus and skeletal system. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.295,Decision to Admit to Hospital Inpatient,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures that are commonly used for capturing an emergency decision to admit a patient to an inpatient hospital setting.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify an emergency decision to admit a patient to an inpatient hospital setting. ),(Inclusion Criteria: Includes only relevant concepts associated with codes representing an emergency decision to admit a patient to an inpatient hospital setting using the SNOMED CT system.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113883.3.526.3.1453,Degeneration of Macula and Posterior Pole,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of degeneration of macula and posterior pole.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of macula and/or posterior pole degenerations, including age-related degenerations, macular cyst, maculopathy, macular puckering, macular hole, atrophy or dystrophy of macula.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1454,Degenerative Disorders of Globe,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of degenerative disorders of globe.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of degenerative disorders of globe, including degenerative myopia, chalcosis, siderosis, and other degenerative diagnoses.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.67.1.101.1.278,Delivery - Diagnosis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses of a live birth or delivery in the outpatient setting.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed. The intent of this data element is identify patients who had a live birth or delivery. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who had a live birth or delivery in the outpatient setting. ),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1078.5,Delivery - Procedure,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent live birth or delivery procedures in the outpatient setting.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed. The intent of this data element is identify patients who had a live birth or delivery. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who had a live birth or delivery in the outpatient setting. ),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.111.12.1015,Delivery Live Births,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent single or multiple live births.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with delivery of one or multiple newborns. This is a grouping of CPT, SNOMED CT and ICD-10-PCS codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1045.59,Delivery Procedures,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent delivery procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify delivery procedures. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying delivery procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1005,Dementia & Mental Degenerations,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent dementia diagnoses and mental degenerations diagnoses.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with dementia diagnoses and mental degeneration diagnoses.),(Exclusion Criteria: Excludes dementia and mental degeneration diagnoses in remission.)"
2.16.840.1.113883.3.464.1003.125.12.1004,Dental Caries,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of dental caries.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who have had dental carries.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1916,Depression Screening  Encounter Codes,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts in which a depression screen could be assessed and documented through an exam, assessment, interview or evaluation.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with wellness visits, annual visits, therapy evaluations, or primary or specialist physician office visits where a depression screen could be conducted.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.145,Depression diagnosis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a current diagnosis of a depressed state or actual depressive disorder whether recurrent, chronic, or diagnosed as moderate, major, or severe.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with depression diagnoses as well as depression as indicated as depressed mood or features, a single episode, or type of psychosis, or a reaction as related to depression.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.469,Depression medications - adolescent,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medications that are commonly used to treat adolescent depression.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with antidepressant medications as well as other recommended depressive management medications, specific to the child and adolescent age group, for depression management.),(Exclusion Criteria: Excludes medications that are not commonly used in the treatment of depression in the child and adolescent age group.)"
2.16.840.1.113883.3.600.470,Depression medications - adult,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medications that are commonly used to treat adult depression.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with antidepressant medications as well as other recommended depressive management medications, specific to the adult age group, for depression management.),(Exclusion Criteria: Excludes medications that are not commonly used in the treatment of depression in the adult age group.)"
2.16.840.1.113883.3.464.1003.196.12.1354,Desiccated Thyroid,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent desiccated thyroid medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; desiccated thyroid medications.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; desiccated thyroid in combination with other medications, synthetic thyroid hormones (e.g. levothyroxine, liothyronine, thyrolar, tirosint).)"
2.16.840.1.113883.3.464.1003.196.12.1278,Desipramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent desipramine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; desipramine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; desipramine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.101.12.1059,Detoxification Visit,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent detoxification visits.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying alcohol and drug detoxification. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1375,Dexbrompheniramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dexbrompheniramine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine in combination with other drugs.)"
2.16.840.1.113883.3.464.1003.196.12.1426,Dexbrompheniramine / Dextromethorphan / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dexbrompheniramine / dextromethorphan / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine / dextromethorphan / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine / dextromethorphan / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1430,Dexbrompheniramine / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dexbrompheniramine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1429,Dexbrompheniramine Maleate / Pseudoephedrine Hydrochloride,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dexbrompheniramine maleate / pseudoephedrine hydrochloride combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine maleate / pseudoephedrine hydrochloride (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine maleate / pseudoephedrine hydrochloride in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1300,Dexchlorpheniramine / Dextromethorphan / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dexbrompheniramine / dextromethorphan / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexchlorpheniramine / dextromethorphan / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; Dexchlorpheniramine / Dextromethorphan / Pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1425,Dexchlorpheniramine / Pseudoephedrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dexbrompheniramine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexchlorpheniramine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexchlorpheniramine / pseudoephedrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1397,Dextromethorphan / Diphenhydramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dextromethorphan / diphenhydramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dextromethorphan / diphenhydramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dextromethorphan / diphenhydramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1452,Dextromethorphan / Doxylamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dextromethorphan / doxylamine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dextromethorphan / doxylamine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dextromethorphan / doxylamine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.103.12.1001,Diabetes,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that identify patients who have a diagnosis of diabetes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who have type I or type II diabetes.),(Exclusion Criteria: Excludes patients who have gestational diabetes or steroid-induced diabetes.)"
2.16.840.1.113883.3.526.3.1455,Diabetic Macular Edema,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of diabetic macular edema.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of diabetic macular edema or diabetic retinopathy with macular edema.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.109.12.1004,Diabetic Nephropathy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of diabetic nephropathy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with patients who have diabetic nephropathy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.327,Diabetic Retinopathy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of diabetic retinopathy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diabetic retinopathy diagnoses.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.600.263,Diagnosis of hypertension,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses and disorders to identify recent onset or evolving hypertension.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients represented by recent onset or evolving diagnosis of hypertension.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.111.12.1008,Diagnostic Studies During Pregnancy,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent diagnostic studies that would be performed during pregnancy on a fetus (e.g., fetal ultrasound).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study, Order. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnostic studies conducted on a fetus. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.109.12.1016,Dialysis Education,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent patients received dialysis education.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Intervention, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with patients who had dialysis education. This includes only relevant concepts associated with education at home.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.109.12.1013,Dialysis Services,eCQM Update 2018-09-17,CPT,2006,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent dialysis services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with patients who had dialysis services.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1279,Dicyclomine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dicyclomine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dicyclomine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dicyclomine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1398,Dienogest / Estradiol Multiphasic,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dienogest / estradiol multiphasic combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dienogest / estradiol multiphasic (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dienogest / estradiol multiphasic in combination with other medications.)"
2.16.840.1.113883.3.117.1.7.1.27,Dietary Intake Other than Breast Milk,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent dietary intake other than breast milk.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Substance. The intent of this data element is to identify dietary intake other than breast milk.),(Inclusion Criteria: Includes only relevant SNOMED CT concepts associated that identify dietary intake other than breast milk.),(Exclusion Criteria: Excludes codes that represent breast milk.)"
2.16.840.1.113883.3.600.1515,Dietary Recommendations,eCQM Update 2018-09-17,HCPCS,2018,2.16.840.1.113883.6.285,"(Clinical Focus: This value set contains concepts that represent dietary management.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with dietary management and nutritional education.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1500,Dimenhydrinate,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dimenhydrinate medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dimenhydrinate only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dimenhydrinate in combination with other medications.)"
2.16.840.1.113762.1.4.1045.56,Dinoprostone,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dinoprostone medications, commonly used in the delivery setting for induction of labor. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive dinoprostone for the purpose of inducing labor.),(Inclusion Criteria: Includes only relevant RxNorm concepts that identify medications that contain dinoprostone as the single ingredient. Drug forms consistent with vaginal administration should be included.),(Exclusion Criteria: Medications that have multiple ingredients should be excluded. Drug forms that are not consistent with vaginal administration should not be included. The codes should be limited to those which are for human use and which are prescribable in the US.)"
2.16.840.1.113883.3.464.1003.196.12.1293,Diphenhydramine / Ibuprofen,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent diphenhydramine / ibuprofen combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; diphenhydramine / ibuprofen (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; diphenhydramine / ibuprofen in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1307,Diphenhydramine / Phenylephrine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent diphenhydramine / phenylephrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; diphenhydramine / phenylephrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; diphenhydramine / phenylephrine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1371,Diphenhydramine Hydrochloride,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent diphenhydramine hydrochloride medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; diphenhydramine hydrochloride only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; diphenhydramine hydrochloride in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1349,Dipyridamole,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent dipyridamole medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dipyridamole only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dipyridamole in combination with other medications.)"
2.16.840.1.113883.3.117.1.7.1.205,Direct Thrombin Inhibitor,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent direct thrombin inhibitor medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a direct thrombin inhibitor.),(Inclusion Criteria: Includes only relevant concepts associated with representing direct thrombin inhibitors. These are RxNorm codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1007,Discharge Services - Hospital Inpatient,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent inpatient hospital discharge services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying hospital discharge day management. This is a grouping of CPT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1006,Discharge Services - Hospital Inpatient Same Day Discharge,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent inpatient hospital same day discharge services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying observation or inpatient care for the evaluation and management of a patient that results in discharge on the same date of admission. This is a grouping of CPT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.11.1065,Discharge Services - Nursing Facility,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have been discharged from a nursing facility.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with discharge from a nursing facility, including a final examination, instructions for continuing care and preparation of discharge records, prescriptions, and referral forms. Discharge services encounters can be less than or over 30 minutes. This is a grouping of CPT codes.),(Exclusion Criteria: Excludes discharges from settings other than a nursing facility.)"
2.16.840.1.113883.3.464.1003.101.12.1013,Discharge Services - Nursing Facility,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have been discharged from a nursing facility.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with discharge from a nursing facility, including a final examination, instructions for continuing care and preparation of discharge records, prescriptions, and referral forms. Discharge services encounters can be less than or over 30 minutes. This is a grouping of CPT codes.),(Exclusion Criteria: Excludes discharges from settings other than a nursing facility.)"
2.16.840.1.113883.3.464.1003.101.12.1039,Discharge Services- Observation Care,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who received observational stay discharge day management.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with services provided to a patient on discharge from outpatient hospital observation status if the discharge is on other than the initial date of observation status.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.87,Discharge To Acute Care Facility,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the discharge of a patient to an acute care facility.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Discharge Disposition. The intent of this data element is to identify the final place or setting to which the patient was discharged on the day of discharge from a particular inpatient encounter. This particular value set intends to identify patients who where discharged to an acute care facility. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing short-term acute care hospitals, including specialty hospitals.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.82,Discharge To Home Or Police Custody,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to represent the discharge of a patient to home or police custody.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Discharge Disposition. The intent of this data element is to identify the final place or setting to which the patient was discharged on the day of discharge from a particular inpatient encounter. This particular value set intends to identify patients who were discharged to home or police custody. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying a patient's discharge destination as either a home setting or police custody.),(Exclusion Criteria: Excludes discharge concepts that identify a patient's discharge status as to anywhere else other than home or police custody.)"
2.16.840.1.113883.3.117.1.7.1.207,Discharged to Health Care Facility for Hospice Care,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to represent the discharge of a patient to a health care facility for hospice care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Discharge Disposition. The intent of this data element is to identify the final place or setting to which the patient was discharged on the day of discharge from a particular inpatient encounter. This particular value set intends to identify patients who where discharged to a health care facility for hospice care. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing health care facilities.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.209,Discharged to Home for Hospice Care,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to represent the discharge of a patient to home for hospice care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Discharge Disposition. The intent of this data element is to identify the final place or setting to which the patient was discharged on the day of discharge from a particular inpatient encounter. This particular value set intends to identify patients who where discharged to home for hospice care.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing discharge to home for hospice care.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.132,Discharged to Rehabilitation Facility,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures that represent the discharge of a patient to rehabilitation facility.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Discharge Disposition. The intent of this data element is to identify the final place or setting to which the patient was discharged on the day of discharge from a particular inpatient encounter. This particular value set intends to identify patients who where discharged to a rehabilitation facility. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing rehabilitation facilities.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1311,Disopyramide,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent disopyramide medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; disopyramide only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; disopyramide in combination with other medications.)"
2.16.840.1.113883.3.526.3.1457,Disorders of Optic Chiasm,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of disorders of optic chiasm.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of optic chiasm disorders or injuries or optic glioma.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1458,Disorders of Visual Cortex,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of disorders of visual cortex.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of a disorder of visual cortex, including inflammatory disorders, neoplasm, and cortical blindness.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.120.12.1001,Disorders of the Immune System,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses affecting the working of the immune system, including disorders of the immunoglobulins and the complement system.),(Data Element Scope: This value set may use the Quality Data Model (QDM)category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses that indicate disorders of the immune system that can interfere with the bodies immune function.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1459,Disseminated Chorioretinitis and Disseminated Retinochoroiditis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of disseminated chorioretinitis and/or retinochoroiditis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of disseminated chorioretinal inflammation, disseminated retinochoroiditis, and placoid pigment epitheliopathy.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.196.12.1410,Drospirenone / Estradiol,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent drospirenone / estradiol combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; drospirenone / estradiol (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; drospirenone / estradiol in combination with other medications.)"
2.16.840.1.113883.3.67.1.101.1.254,Dysthymia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses related to dysthymia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses for dysthymia, including early and late onset, and primary and secondary dysthymia. This groups ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.2448,ECG 12 lead or study order,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent electrocardiogram (ECG) 12-lead studies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with for ECG 12-lead or study order.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.109.12.1014,ESRD Monthly Outpatient Services,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who had ESRD monthly outpatient services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who had ESRD monthly outpatients services.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1537,Egg Substance,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent an allergy or intolerance to an egg substance.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Allergy/Intolerance.),(Inclusion Criteria: Includes only relevant concepts associated with an allergy or intolerance to an egg substance.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1047,Ehlers Danlos Syndrome,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of Ehlers-Danlos syndrome.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for Ehlers-Danlos syndrome. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1134,Ejection Fraction,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent ejection fraction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study.),(Inclusion Criteria: Includes only relevant concepts associated with studies specific to obtaining left ventricular ejection fraction.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.735,Electrocardiogram (ECG),eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to define electrocardiogram (ECG).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study. The intent of this data element is to identify patients who had an electrocardiogram (ECG) diagnostic test.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who had an electrocardiogram (ECG).),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.292,Emergency Department Visit,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures representing an emergency department encounter.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have had an emergency department encounter. ),(Inclusion Criteria: Includes only relevant concepts associated with an emergency department visit encounter using the SNOMED CT code system.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1010,Emergency Department Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an interaction with a member of their medical care team in the emergency department.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with care provided to new and established patients in the emergency department. This is a value set grouping that includes CPT and SNOMED CT codes.),(Exclusion Criteria: Excludes services not performed in the emergency department, including critical care and observation services.)"
2.16.840.1.113883.3.464.1003.114.12.1007,Encephalopathy due to Childhood Vaccination,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of encephalopathy due to childhood vaccination.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with encephalopathy (a brain injury) due to childhood vaccination.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.307,Encounter Inpatient,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the most common inpatient encounter types.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have had an inpatient encounter. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing inpatient encounter.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1252,Encounter-Influenza,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits during which an influenza vaccine may be administered.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with face-to-face encounters during which an influenza vaccine may be administered.),(Exclusion Criteria: Excludes telehealth encounters.)"
2.16.840.1.113883.3.526.3.353,End Stage Renal Disease,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of end stage renal disease.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of end stage renal disease.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1045.69,Endotracheal Intubation,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent procedures used to define endotracheal intubation.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who received endotracheal intubation as a medical procedure. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who had endotracheal intubation. This is a grouping of ICD-10-PCS and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1421,Enophthalmos,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of enophthalmos.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of enophthalmos.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.104.12.1011,Essential Hypertension,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent essential hypertension.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who are diagnosed with essential hypertension.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1419,Esterified Estrogens,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent esterified estrogen medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; esterified estrogen medications.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; esterified estrogens in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1320,Esterified Estrogens / Methyltestosterone,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent esterified estrogens / methyltestosterone combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; esterified estrogens / methyltestosterone (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; esterified estrogens / methyltestosterone in combination with other medications.)"
2.16.840.1.113762.1.4.1045.47,Estimated Gestational Age at Birth,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent estimated gestational age at birth.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment. The intent of this data element is to identify estimated gestational age at birth. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify estimated gestational age at birth.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113762.1.4.1045.26,Estimated Gestational Age at Delivery,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent ""observable entities"" that represent the estimated gestational age at delivery.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment. The intent of this data element is to identify the fetus's estimated length of gestation at delivery.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify the estimated gestational age at delivery.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1365,Estradiol,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent estradiol medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; estradiol only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; estradiol in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1323,Estradiol / Norethindrone,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent estradiol / norethindrone combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; estradiol / norethindrone (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; estradiol / norethindrone in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1319,Estropipate,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent estropipate medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; estropipate only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; estropipate in combination with other medications.)"
2.16.840.1.114222.4.11.837,Ethnicity,eCQM Update 2018-09-17,CDCREC,1.2,2.16.840.1.113883.6.238,"(Clinical Focus: This value set contains concepts that represent whether the patient is Hispanic or not; ethnicity category defined by the Centers for Disease Control and Prevention and National Center for Health Statistics.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Ethnicity.),(Inclusion Criteria: Includes only relevant concepts associated with ethnicity defined as Hispanic or Latino, or Not Hispanic or Latino.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1422,Excision of Adhesions,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures of excision of adhesions.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with procedures of severing or lysis of adhesions of the anterior segment of the eye.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.108.12.1039,FIT DNA,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent a fecal immunochemical (FIT) DNA test. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying a FIT DNA laboratory test. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes codes that indicate that this test was ordered only, and not necessarily performed.)"
2.16.840.1.113883.3.464.1003.118.12.1028,Falls Screening,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent assessment tools or instruments used to quantify fall risk.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with fall risk assessment tools and screening assessments used to evaluate fall risk such as the Get Up and Go Test, Morse falls risk assessment, multidisciplinary team falls assessment, and history of falls. This is a grouping of LOINC and SNOMED CT codes.),(Exclusion Criteria: Excludes codes that indicate falls for children or falls that take place in an inpatient setting.)"
2.16.840.1.113883.3.464.1003.198.12.1011,Fecal Occult Blood Test (FOBT),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent a fecal occult blood test.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying tests for occult blood in stool. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes tests for occult blood in other parts of the body. Excludes codes that indicate that this test was ordered only, and not necessarily performed.)"
2.16.840.1.113883.3.560.100.2,Female,eCQM Update 2018-09-17,AdministrativeGender,HL7V3.0_2017-07,2.16.840.1.113883.5.1,"(Clinical Focus: This value set contains concepts that represent female.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Sex. ),(Inclusion Criteria: Includes only relevant concepts associated with appropriate female gender concepts.),(Exclusion Criteria: Excludes concepts representing male gender.)"
2.16.840.1.113883.3.666.5.736,Fibrinolytic Therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medications that are prescribed for fibrinolytic therapy in patients with an episode of acute myocardial infarction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Administered. The intent of this data element is to identify patients who are prescribed fibrinolytic therapy during an episode of an acute myocardial infarction.),(Inclusion Criteria: Includes only relevant concepts associated with generic and prescribable fibrinolytic agents. Only injectable dose forms should be included. Single ingredient.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1010,Flexible Sigmoidoscopy,eCQM Update 2018-09-17,CPT,2014,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent a flexible sigmoidoscopy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying a flexible sigmoidoscopy. This is a grouping of CPT, HCPCS and SNOMED CT codes.),(Exclusion Criteria: Excludes codes that indicate that this test was ordered only, and not necessarily performed.)"
2.16.840.1.113883.3.464.1003.125.12.1002,Fluoride Varnish Application for Children,eCQM Update 2018-09-17,CDT,2018,2.16.840.1.113883.6.13,"(Clinical Focus: This value set contains concepts that represent a fluoride varnish application.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who received a fluoride varnish application.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1460,Focal Chorioretinitis and Focal Retinochoroiditis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of focal chorioretinitis and/or retinochoroiditis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of focal chorioretinitis, choroiditis, retinochoroiditis and retinitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.600.467,Follow-up for depression - adolescent,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent follow-up plans used to document a plan is in place for the treatment of depression that specifically pertains to the adolescent population.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with emotional and coping support as well as mental health management in an attempt to follow up on previously evaluated and diagnosed depression or depressive disorder in the adolescent population.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.468,Follow-up for depression - adult,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent follow-up plans used to document a plan is in place for the treatment of depression specifically pertaining to the adult population.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with emotional and coping support as well as mental health management in an attempt to follow up on previously evaluated and diagnosed depression or depressive disorder in the adult population.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1537,Followup within 4 weeks,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent capturing the follow-up encounter within four weeks of the initial encounter.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. Intention to represent follow-up visits within a 4-week period.),(Inclusion Criteria: Includes only relevant concepts associated with capturing the follow up between 1 day to 1 month of the initial finding.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1474,Followup within one year,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent capturing the follow-up encounter within one year of the initial encounter.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. Intention to represent follow-up visits within a one-year period.),(Inclusion Criteria: Includes only relevant concepts associated with capturing the follow up between 1 day to 12 month of the initial finding.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1037,Fracture - Lower Body,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of fracture of a bone in the leg or pelvis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of fracture of the ankle, ilium, acetabulum, pubis, ischium, epiphysis, femur, patella, leg, tibia, fibula, talus, calcaneus, or metatarsal. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes that identify pathological or nontraumatic fractures.)"
2.16.840.1.113883.3.117.1.7.1.35,Galactosemia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses that represent galactosemia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. The intent of this data element is to identify galactosemia. ),(Inclusion Criteria: Includes only relevant concepts associated with ICD-10-CM and SNOMED CT codes that identify galactosemia.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113883.3.464.1003.198.12.1050,Gastric Bypass Surgery,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent codes that can be used to identify patients who have undergone a partial or total removal of the stomach by either a laparoscopic or open method.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying procedures for repair or removal of digestive system organs that includes a partial or total removal of the stomach. This is a grouping of CT and SNOMED CT codes.),(Exclusion Criteria: Excludes endoscopic excision of tissue of stomach, excision/laparoscopic wedge resection of lesion of stomach and incisional biopsy of stomach.)"
2.16.840.1.113883.3.117.1.7.1.255,General Surgery,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent a general surgery procedure. These surgical procedures are thoracic and abdominal procedures, except for cardiac procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have general surgery procedures.),(Inclusion Criteria: Includes only relevant concepts associated with representing general surgery. These surgical procedures are thoracic and abdominal procedures, except for cardiac procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.1743,General or Neuraxial Anesthesia,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent a surgical procedure where a general and/or neuraxial anesthesia is used.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have a surgical procedure where general and/or neuraxial anesthesia is used.),(Inclusion Criteria: Includes only relevant concepts associated with representing general and/or neuraxial anesthesia. Codes used are to be ICD-10-PCS, ICD-9 or SNOMED CT codes only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1049,Genital Herpes,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent genital herpes infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with female genital herpes infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes that indicate male genital herpes infections.)"
2.16.840.1.113883.3.526.3.1423,Glaucoma,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of glaucoma.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of glaucoma.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1461,"Glaucoma Associated with Congenital Anomalies, Dystrophies, and Systemic Syndromes",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of glaucoma that is associated with congenital anomalies, dystrophies, and systemic syndromes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of glaucoma that may be due to congenital anomalies, dystrophies, or other systemic syndromes, including trauma, or a secondary diagnosis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.109.12.1018,Glomerulonephritis and Nephrotic Syndrome,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of glomerulonephritis and nephrotic syndrome.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who are diagnosed with glomerulonephritis and nephrotic syndrome.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1266,Glucocorticoids (oral only),eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent glucocorticoid medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; cortisone, dexamethasone, hydrocortisone, prednisone, methyprednisone, triamcinolone, betamethasone, dexamethasone, fludrocortisone and triamcinolone. Includes only relevant concepts associated with only glucocorticoids taken orally, i.e., through an tablet, capsule, or oral solution.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; glucorticoids in combination with other drugs. Excludes all glucocorticoids taken non-orally, i.e., as a nasal inhalant or injectable solution.)"
2.16.840.1.113883.3.464.1003.196.12.1368,Glyburide,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent glyburide medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; glyburide only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; glyburide in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1360,Glyburide / Metformin,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent glyburide / metformin combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; glyburide / metformin (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; glyburide / metformin in combination with other medications.)"
2.16.840.1.113762.1.4.1045.41,Glycoprotein IIb/IIIa Inhibitors,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent codes that identify glycoprotein Iib/IIIa inhibitors.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a glycoprotein Iib/IIIa inhibitor. ),(Inclusion Criteria: Includes only relevant concepts associated with a glycoprotein Iib/IIIa inhibitor. These are RxNorm codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.112.12.1001,Gonococcal Infections and Venereal Diseases,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent gonococcal infections and other venereal diseases.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with female gonococcal infections and other venereal disease. This is a grouping of ICD-10-CM, ICD-9-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes that indicate male gonococcal infections or male venereal disease.)"
2.16.840.1.113883.3.117.1.7.1.256,Graduated compression stockings (GCS),eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent graduated compression stocking devices that are used to prevent VTEs in patients.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Device. The intent of this data element is to identify patients who have a graduated compression stocking device applied. It may also be used to identify patients who did not have a graduated compression stocking device applied for VTE prophylaxis for an allowable reason when used with a negation rationale attribute. ),(Inclusion Criteria: Includes only relevant concepts associated with graduated compression stockings.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1012,Group A Streptococcus Test,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests for group A streptococcus.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test.),(Inclusion Criteria: Includes only relevant concepts associated with laboratory tests used to identify the presence of group A streptococcus in the throat.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1187,Group Psychotherapy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits during which group psychotherapy is performed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with group psychotherapy.),(Exclusion Criteria: Excludes family psychotherapy or individual psychotherapy.)"
2.16.840.1.113883.3.464.1003.196.12.1341,Guanfacine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent guanfacine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; guanfacine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; guanfacine in combination with other medications.)"
2.16.840.1.113883.3.117.1.7.1.257,Gynecological Surgery,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent procedures of gynecologic surgery.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have a gynecologic surgery procedure.),(Inclusion Criteria: Includes only relevant concepts associated with representing gynecologic surgery procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.67.1.101.1.279,HBsAg,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: Under development),(Data Element Scope: Under development),(Inclusion Criteria: Under development),(Exclusion Criteria: Under development)"
2.16.840.1.113883.3.464.1003.120.12.1003,HIV,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent human immunodeficiency virus (HIV) disease.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with HIV and acquired immunodeficiency syndrome. This is a grouping of ICD-10-CM, ICD-9-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.120.12.1004,HIV 1,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of human immunodeficiency virus (HIV), type 1; HIV; or acquired immunodeficiency syndrome (AIDS).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with that identify patients with a diagnosis of HIV, type; HIV; or AIDS. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes for HIV, type 2.)"
2.16.840.1.113883.3.464.1003.110.12.1059,HPV Test,eCQM Update 2018-09-17,LOINC,2.56,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent identify high-risk human papilloma virus (HPV) tests. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with high-risk HPV tests performed on cervical samples. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes high-risk HPV tests conducted on non-cervical samples. Excludes codes that indicate that this test was ordered only, and not necessarily performed.)"
2.16.840.1.113883.3.464.1003.196.12.1217,Haemophilus Influenzae Type B (HiB) Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent Haemophilus influenzae type B (Hib) vaccine codes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all Haemophilus influenzae type b (Hib) vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1043,Haemophilus Influenzae Type B (HiB) Vaccine Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedure codes for Haemophilus influenzae type B (Hib) vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all Haemophilus influenzae type b (Hib) vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1013,HbA1c Laboratory Test,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent hemoglobin A1c laboratory tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test.),(Inclusion Criteria: Includes only relevant concepts associated with identifying hemoglobin A1c laboratory tests.),(Exclusion Criteria: Excludes codes that identify hemoglobin A1c laboratory tests that use the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)   protocol and Japanese Diabetes Society (JDS)/Japanese Society of Clinical Chemistry (JSCC) protocol. )"
2.16.840.1.113883.3.526.3.1020,Health & Behavioral Assessment - Individual,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits for health and behavior intervention for an individual patient.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with encounter codes specific to intervention for health and/or behavioral factors, which involve an individual patient.),(Exclusion Criteria: Excludes encounters for group settings.)"
2.16.840.1.113883.3.526.3.1245,Health and Behavioral Assessment - Initial,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent initial visits for health and behavior assessments for an individual patient.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with encounter codes specific to the initial assessment of health and/or behaviors, which involve an individual patient.),(Exclusion Criteria: Excludes encounters for group settings.)"
2.16.840.1.113883.3.526.3.1529,"Health and Behavioral Assessment, Reassessment",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent initial visits for health and behavior reassessments for an individual patient.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with encounter codes specific to subsequent assessment or reassessment of health and/or behaviors, which involve an individual patient.),(Exclusion Criteria: Excludes encounters for group settings.)"
2.16.840.1.113883.3.526.3.376,Heart Failure,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of heart failure.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of heart failure.),(Exclusion Criteria: Excludes chronic and acute right-sided heart failure, right heart failure, right ventricular failure, cardiac insufficiency due to prosthesis and following cardiac surgery, or pulmonale.)"
2.16.840.1.113883.3.464.1003.121.12.1014,Height,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent a patient's height has been measured or observed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Physical Exam, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying if a patient's height has been measured or observed. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes codes that are expressed as a percentile, stated by a patient, post-partum or estimated.)"
2.16.840.1.113883.3.526.3.1083,Hemodialysis,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent the administration of hemodialysis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with the administration of hemodialysis.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.212,Hemorrhagic Stroke,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set grouping contains concepts that represent patients who have had a hemorrhagic stroke, or stroke caused by hemorrhage.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Principal Diagnosis. The intent of this data element is to identify patients who have a diagnosis of hemorrhagic stroke, or stroke caused by a hemorrhage. ),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of hemorrhagic stroke, or stroke caused by hemorrhage. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1024,Hepatitis A,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent hepatitis A infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with hepatitis A infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1215,Hepatitis A Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent hepatitis A vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant hepatitis A vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1041,Hepatitis A Vaccine Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedure codes for hepatitis A vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with hepatitis A vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1025,Hepatitis B,eCQM Update 2018-09-17,ICD10CM,2016,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent hepatitis B infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with hepatitis B infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.67.1.101.1.269,Hepatitis B,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent acute or chronic hepatitis B infection.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnosis, Active. The intent of this data element is identify patients with acute or chronic hepatitis B infection. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients with acute or chronic hepatitis B infection.),(Exclusion Criteria: Excludes patients with evidence of current or past acute or chronic hepatitis B infection.)"
2.16.840.1.113883.3.464.1003.196.12.1216,Hepatitis B Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent hepatitis B vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant hepatitis B vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1042,Hepatitis B Vaccine Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures for hepatitis B vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant hepatitis B vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1462,Hereditary Choroidal Dystrophies,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of hereditary choroidal dystrophies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of hereditary choroidal dystrophies, including choroideremia and atrophy.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1424,Hereditary Corneal Dystrophies,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of hereditary corneal dystrophies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of hereditary corneal dystrophies, including congenital, epithelial/juvenile, granular, lattice or macular corneal dystrophies.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1463,Hereditary Retinal Dystrophies,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of hereditary retinal dystrophies.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of hereditary retinal or vitreoretinal dystrophies, including Usher syndrome.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1425,High Hyperopia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of high hyperopia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of high hyperopia or hypermetropia.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.196.12.1253,High Risk Medications for the Elderly,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent high risk medications at any dose and for any duration for the elderly.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human only; prescribable; medications considered high risk for the elderly.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable medications.)"
2.16.840.1.113762.1.4.1047.97,High intensity statin therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent high intensity statin medications as defined by the 2013 American College of Cardiology (ACC) and the American Heart Association (AHA) guideline.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with high intensity statin therapy medications.),(Exclusion Criteria: Excludes any other intensity of statin therapy.)"
2.16.840.1.113883.3.464.1003.196.12.1254,High-Risk Medications With Days Supply Criteria,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent high risk medications at any dose with greater than a 90-day supply for the elderly.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human only; prescribable; high risk drugs at any dose with greater than a 90-day supply for the elderly.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable medications.)"
2.16.840.1.113883.3.464.1003.118.12.1210,Hip Dysfunction and Osteoarthritis Outcome Score for Joint Replacement [HOOSJR],eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Hip Dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS Jr.) total interval score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying the Hip Dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS Jr.) total interval score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.258,Hip Fracture Surgery,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent procedures of hip fracture surgery.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have a hip fracture surgery procedure. ),(Inclusion Criteria: Includes only relevant concepts associated with representing hip fracture surgery.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.259,Hip Replacement Surgery,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent total hip replacement procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have a total hip replacement procedure.),(Inclusion Criteria: Includes only relevant concepts associated with representing the surgical procedure of a total hip replacement.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1068,History of bilateral mastectomy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a previous history of bilateral mastectomy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with patients that have ever had a bilateral mastectomy performed. This is a grouping of SNOMED CT and ICD-10-CM codes.),(Exclusion Criteria: Excludes codes that indicate a unilateral mastectomy or are unspecified.)"
2.16.840.1.113883.3.464.1003.113.12.1040,History of hip fracture in parent,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a family history of fracture in a parent.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with a patient has a family history of fracture in a parent. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1016,Home Healthcare Services,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had a home health visit by a provider for the evaluation or management of a new or existing patient.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with home visits for the evaluation and management of a new or established patient. This is a grouping value set of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1108.15,Hospice care ambulatory,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent patients receiving hospice care outside of a hospital or long term care facility.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Order or Intervention, Order. The intent of this value set is to identify all patients receiving hospice care outside of a hospital or long term care facility. ),(Inclusion Criteria: Includes only relevant concepts associated with hospice care concepts.),(Exclusion Criteria: Excludes concepts for palliative care or comfort measures.)"
2.16.840.1.113883.3.464.1003.101.12.1004,Hospital Inpatient Visit - Initial,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent inpatient hospital visits.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with initial hospital care for the evaluation and management of a patient. This is a grouping of CPT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1002,Hospital Observation Care - Initial,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent initial inpatient hospital observation care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with initial observation care for the evaluation and management of a patient. This is a grouping of CPT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1111.126,Hospital Settings,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent hospital environments where a patient received inpatient or outpatient care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category Encounter or attribute Admission Source. The intent of this data element is to identify hospital environments where a patient may receive inpatient or outpatient care.),(Inclusion Criteria: Includes only relevant concepts associated with hospital environment and all its children. Codes used are to be SNOMED CT codes only. ),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1056.50,Human Immunodeficiency Virus (HIV) Laboratory Test Codes (Ab and Ag),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests used for Human Immunodeficiency Virus screening.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test. Used for HIV screening. ),(Inclusion Criteria: Includes only relevant concepts associated with laboratory tests for HIV-1 and HIV-2 antibodies or antigens.
),(Exclusion Criteria: Excludes tests and procedures that might be associated with HIV infection that are not used for screening or testing to establish an HIV diagnosis, which would include home/self HIV testing, HIV genotyping tests, HIV RNA tests, HIV cultures, clinical codes used to document care provided to HIV-infected patients.)"
2.16.840.1.113883.3.464.1003.196.12.1414,Hydrochlorothiazide / Methyldopa,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent glyburide / metformin combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hydrochlorothiazide / methyldopa (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hydrochlorothiazide / methyldopa in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1374,Hydroxyzine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent hydroxyzine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hydroxyzine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hydroxyzine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1501,Hyoscyamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent hyoscyamine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1503,Hyoscyamine / Methenamine / Mblue / Phenyl Salicyl,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent hyoscyamine / methenamine / mblue / phenyl salicyl combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1504,Hyoscyamine / Methenamine / Mblue / Phenyl Salicyl / Sodium Biphosphate,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent hyoscyamine / methenamine / mblue / phenyl salicyl / sodium biphosphate combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl / sodium biphosphate (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl / sodium biphosphate in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1505,Hyoscyamine / Methenamine / Mblue / Sodium Biphosphate,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent hyoscyamine / methenamine / mblue / sodium biphosphate combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine / methenamine / mblue / sodium biphosphate (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine / methenamine / mblue / sodium biphosphate in combination with other medications.)"
2.16.840.1.113762.1.4.1047.100,Hypercholesterolemia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis, past or present, of hypercholesterolemia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attributes related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses of hypercholesterolemia.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.117.12.1016,Hyperparathyroidism,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of hyperparathyroidism.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes associated with hyperparathyroidism, including primary, secondary, tertiary, and all other types of hyperparathyroidism. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes diagnoses of autonomous thyroid function, Iatrogenic thyrotoxicosis factitia, neonatal thyrotoxicosis and thyrotoxic crisis.)"
2.16.840.1.113883.3.464.1003.109.12.1017,Hypertensive Chronic Kidney Disease,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent hypertensive kidney disease.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with hypertensive kidney disease.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.117.12.1015,Hyperthyroidism,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of hyperthyroidism.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with all diagnosis codes for thyrotoxicosis, both with and without thyrotoxic crisis or storm, and with and without presence of goiter. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes diagnosis codes for neonatal thyrotoxicosis.)"
2.16.840.1.113883.3.526.3.370,Hypotension,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of hypotension.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of hypotension.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1426,Hypotony of Eye,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of hypotony of eye.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of hypotony of eye.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.198.12.1014,Hysterectomy with No Residual Cervix,eCQM Update 2018-09-17,CPT,1998,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that identify hysterectomy procedures that include removal of the patient's cervix.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with total or radical hysterectomies. This is a grouping of CPT, SNOMED CT, ICD-10-PCS and ICD-9-CM codes.),(Exclusion Criteria: Excludes partial hysterectomies and hysterectomies that leave the patient's cervix intact.)"
2.16.840.1.113883.3.117.1.7.1.213,INR,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent codes for laboratory test for INR, or international normalized ratio.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test. The intent of this data element is to identify INR laboratory tests. ),(Inclusion Criteria: Includes only relevant concepts associated with a laboratory test of INR (International Normalized Ratio). These are LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1359,Imipramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent imipramine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; imipramine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; imipramine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1219,Inactivated Polio Vaccine (IPV),eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent inactivated polio vaccines (IPV).),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all inactivated polio vaccine (IPV) codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1045,Inactivated Polio Vaccine (IPV) Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures for inactivated polio vaccine (IPV) administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all inactivated polio vaccine (IPV) administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1366,Indomethacin,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent indomethacin medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; indomethacin only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; indomethacin in combination with other medications.)"
2.16.840.1.113883.3.464.1003.112.12.1004,Inflammatory Diseases of Female Reproductive Organs,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent inflammatory disease of female reproductive organs.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with inflammatory diseases of female reproductive organs. This is a grouping of ICD-10-CM, ICD-9-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.402,Influenza Vaccination,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent influenza vaccinations.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with influenza vaccinations that are SNOMED CT, CPT, and HCPCS codes. ),(Exclusion Criteria: Excludes CVX vaccine codes.)"
2.16.840.1.113883.3.526.3.1255,Influenza Vaccination Declined,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a patient declining an influenza vaccination.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication.),(Inclusion Criteria: Includes only relevant concepts associated with a patient declining an influenza vaccination.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1218,Influenza Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent influenza vaccine codes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with influenza vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1254,Influenza Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent influenza vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Immunization.),(Inclusion Criteria: Includes only relevant concepts associated with CVX concepts related to influenza vaccines.),(Exclusion Criteria: Excludes HCPCS, SNOMED CT and CPT influenza vaccine codes.)"
2.16.840.1.113883.3.464.1003.110.12.1044,Influenza Vaccine Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures for influenza vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant influenza vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.211,Injectable Factor Xa Inhibitor for VTE Prophylaxis,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent codes which identify injectable factor Xa inhibitors, which are used for venous thromboembolism (VTE) prophylaxis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a select injectable factor Xa inhibitor as prophylaxis for VTE. ),(Inclusion Criteria: Includes only relevant concepts associated with injectable factor Xa inhibitor medications. These are RxNorm codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1151.16,Injection Leuprolide Acetate,eCQM Update 2018-09-17,HCPCS,2018,2.16.840.1.113883.6.285,"(Clinical Focus: This value set contains concepts that represent codes for injection of leuprolide acetate for intended twelve-month period.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to include androgen deprivation therapy for equal to or greater than 12 months. This is accomplished by indicating the CPT code and then a modifier such as J1950,cont which is non-billable but allows for reporting the intent.),(Inclusion Criteria: Includes only relevant HCPCS concepts associated with injection of leuprolide acetate intended for 12 months or greater.),(Exclusion Criteria: Excludes injection of leuprolide acetate intended for a period of less than 12 months.)"
2.16.840.1.113883.3.526.3.1427,Injury to Optic Nerve and Pathways,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of injury to optic nerve and optic pathways.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of injuries to optic nerve, optic chiasm, optic tract, optic pathways and optic visual cortex.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.101.12.1060,Inpatient Encounter,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent inpatient encounters.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying inpatient encounters.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.378,Instructions for Follow Up After Discharge,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent follow-up care after discharge or follow-up care planned and scheduled.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication. The intent of this data element is to identify patients who receive instructions for follow up after discharge or have follow-up plans scheduled. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing instructions for follow up after discharge or follow-up care planned and scheduled.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113762.1.4.1110.23,Intensive Care Unit,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent codes for intensive care units (ICU).),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed. The intent of this data element is to identify patients in intensive care units. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing adult and pediatric intensive care units (ICU).),(Exclusion Criteria: Excludes codes for neonatal intensive care units (NICU).)"
2.16.840.1.113883.3.117.1.7.1.214,Intermittent pneumatic compression devices (IPC),eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent intermittent pneumatic compression devices used for venous thromboembolism (VTE) prophylaxis. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Device. The intent of this data element is to represent the application of certain intermittent pneumatic compression devices. ),(Inclusion Criteria: Includes only relevant concepts associated with representing different types of intermittent pneumatic compression devices.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1212,Intolerance to ACE Inhibitor or ARB,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of intolerance to angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blockers (ARB). ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of intolerance to ACE inhibitor or ARB.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1178,Intolerance to Beta Blocker Therapy,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of intolerance to beta blocker therapy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of intolerance to beta blocker therapy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1257,Intolerance to Influenza Vaccine,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of intolerance to influenza vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of intolerance to influenza vaccines.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.260,Intracranial Neurosurgery,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent procedures of intracranial neurosurgery.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have an intracranial neurosurgery procedure.),(Inclusion Criteria: Includes only relevant concepts associated with representing intracranial neurosurgery.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1045.21,Intravenous or Intra-arterial Thrombolytic (t-PA) Therapy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set grouping contains concepts that represent intravenous or intra-arterial thrombolytic (t-PA) therapy procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify intravenous or intra-arterial thrombolytic (t-PA) therapy procedures.),(Inclusion Criteria: Includes only relevant concepts associated with identifying intravenous or intra-arterial thrombolytic (t-PA) therapy procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.222,Intravenous route,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the route by which a medication is administered, in this case an intravenous route.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Route. The intent of this data element is to identify the route by which a medication is administered, in this case an intravenous route. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying an intravenous route for giving a medication. Codes used are to be SNOMED CT codes only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.199.12.1056,Intussusception,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of intussusception.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of intussusception (a condition of the intestines).),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.247,Ischemic Stroke,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set grouping contains concepts that represent patients who have had a stroke caused by ischemia, where the blood supply is restricted to an area of the brain by something like thrombosis or an embolism.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis. The intent of this data element is to identify patients who have a diagnosis of ischemic stroke, or stroke caused by ischemia.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of ischemic stroke, or stroke caused by ischemia. This is a grouping of ICD-10-CM and SNOMED CT codes and concepts.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.104.12.1003,Ischemic Vascular Disease,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent ischemic vascular disease.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes to identify ischemic vascular disease.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.46,"Ischemic heart disease or coronary occlusion, rupture, or thrombosis",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent ischemic heart disease and associated diagnoses as related to atherosclerotic cardiovascular disease (ASCVD).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with acute and chronic forms of ischemic heart disease as well as coronary occlusion, thrombosis, or rupture that can be related to ASCVD.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1143,Isotretinoin,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent isotretinoin medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; isotretinoin only. This is a grouping of RxNorm codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1422,Isoxsuprine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent isoxsuprine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; isoxsuprine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; isoxsuprine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.118.12.1220,KCCQ Physical Limitation Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Kansas City Cardiomyopathy Questionnaire (KCCQ) physical limitation score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Kansas City Cardiomyopathy Questionnaire (KCCQ) physical limitation score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1221,KCCQ Self Efficacy Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Kansas City Cardiomyopathy Questionnaire (KCCQ) self-efficacy score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Kansas City Cardiomyopathy Questionnaire (KCCQ) self-efficacy score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1222,KCCQ Social Limitation Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Kansas City Cardiomyopathy Questionnaire (KCCQ) social limitation score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Kansas City Cardiomyopathy Questionnaire (KCCQ) social limitation score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1223,KCCQ Total Symptom Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Kansas City Cardiomyopathy Questionnaire (KCCQ) total symptom score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Kansas City Cardiomyopathy Questionnaire (KCCQ) total symptom score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1364,Ketorolac Tromethamine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent ketorolac tromethamine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; ketorolac tromethamine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; ketorolac tromethamine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.109.12.1028,Kidney Failure,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent kidney failure.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes to identify kidney failure and kidney disease. ),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.109.12.1012,Kidney Transplant,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have undergone kidney transplant.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with kidney transplants.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.109.12.1029,Kidney Transplant Recipient,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent recipients of kidney transplants.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying kidney transplant recipients.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1153,Knee Dysfunction and Osteoarthritis Outcome Score [KOOS] Activities of Daily Living Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) activities of daily living score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) activities of daily living score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1180,Knee Dysfunction and Osteoarthritis Outcome Score [KOOS] Pain Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) pain score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) pain score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1152,Knee Dysfunction and Osteoarthritis Outcome Score [KOOS] Sport Recreation Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) sport recreation score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) sport recreation score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1182,Knee Dysfunction and Osteoarthritis Outcome Score [KOOS] Symptoms Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) symptoms score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Knee Dysfunction and Osteoarthritis Outcome Score (KOOS) symptoms score. This is a grouping of a LOINC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1218,Knee Injury and Osteoarthritis Outcome Score for Joint Replacement [KOOSJR],eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS Jr.) total interval score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS Jr.) score. This is a grouping of a LOINC code.
.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.261,Knee Replacement Surgery,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent total knee replacement procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have a total knee replacement procedure.),(Inclusion Criteria: Includes only relevant concepts associated with surgical procedure of a total knee replacement.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.11.1029,LDL Test,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent low-density lipoprotein (LDL) tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the calculation or measurement of LDL. This is a grouping of LOINC concepts.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.215,LDL-c,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent lab tests commonly used for low-density lipoproteins (LDL) cholesterol measurement.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test. The intent of this data element is to identify patients who had a lab test on a source of serum or plasma.),(Inclusion Criteria: Includes only relevant concepts associated with LDL-C tests using the source of serum or plasma based on a measurement scale of mass per volume.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.111.12.1007,Lab Tests During Pregnancy,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent lab tests conducted during pregnancy (e.g., tests conducted on amniotic fluid).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test.),(Inclusion Criteria: Includes only relevant concepts associated with laboratory tests conducted during pregnancy. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1051,Lab Tests for Sexually Transmitted Infections,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests for sexually transmitted infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test, Order. ),(Inclusion Criteria: Includes only relevant concepts associated with laboratory tests for sexually transmitted infections in females. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes codes that indicate lab tests for sexually transmitted infections in male patients.)"
2.16.840.1.113883.3.117.1.7.1.281,Labor,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent labor.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Physical Exam. The intent of this data element is to identify that a patient is in labor. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify onset and establishment of labor.),(Exclusion Criteria: Excludes codes describing later stages of labor and latent labor.)"
2.16.840.1.113883.3.600.1482,Laboratory Tests for Hypertension,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests that are commonly used with patients diagnosed with hypertension.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. ),(Inclusion Criteria: Includes only relevant concepts associated with laboratory testing for patients diagnosed with hypertension.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.122.12.1036,Left,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the left side of the body.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Anatomical Location Site.),(Inclusion Criteria: Includes only relevant concepts associated with the left side of the body. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: Excludes concepts representing the right side of the body.)"
2.16.840.1.113883.3.117.1.7.1.308,Left Against Medical Advice,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a patient leaving against medical advice.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Discharge status. The intent of this data element is to identify the final place or setting to which the patient was discharged on the day of discharge from a particular inpatient encounter. This particular value set intends to identify patients who left against medical advice. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing leaving against medical advice.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1058,Left Unilateral Amputation Above or Below Knee,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a left unilateral amputation procedure, above or below the knee.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying left unilateral amputations above or below the knee.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1072,Left Unilateral Amputation Procedure Above or Below Knee,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a left unilateral amputation procedure, above or below the knee.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying unilateral amputation procedure above or below the knee.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1091,Left Ventricular Systolic Dysfunction,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of left ventricular systolic dysfunction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of left ventricular systolic dysfunction.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1429,Lens Procedure,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent types of lens procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with procedures of the lens, including exchange of intraocular lens, removal or repositioning of lens or lens prosthesis.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1205,Leucovorin,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent leucovorin medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Order.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; leucovorin only.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; leucovorin in combination with other medications.)"
2.16.840.1.113883.3.526.3.1283,Level of Severity of Retinopathy Findings,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the level of severity of retinopathy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication, or could be used as a Diagnosis, or as an attribute to represent exam findings.),(Inclusion Criteria: Includes only relevant concepts associated with mild non-proliferative, moderate non-proliferative, severe non-proliferative, very severe non-proliferative, and proliferative diabetic retinopathy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1508,Lifestyle Recommendation,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the type of interventions relevant to lifestyle needs.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure or Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with the type of lifestyle education provided.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1259,Limited Life Expectancy,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent limited life expectancy, including poor prognosis or terminal illness.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. The intent of this data element is to identify patients who are deemed to have limited life expectancy.),(Inclusion Criteria: Includes only relevant concepts associated with conveying a poor prognosis for patient’s health status, as well as terminal or pre-terminal illness.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1272,List of Single RxNorm Code Concepts for High Risk Drugs for the Elderly,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medication concepts considered as high risk for the elderly.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; medications considered high risk for the elderly.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable medications.)"
2.16.840.1.113762.1.4.1046.6,Live Birth Newborn Born in Hospital,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses that are commonly used in the inpatient setting for newborn live born, and born in hospital. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype or attribute related to Diagnosis. The intent of this data element is to identify patients who have active diagnosis of live birth newborn born in hospital.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis of live birth newborn born in hospital. This value set Includes ICD-10-CM and SNOMED CT value sets.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.42,Liver Disease,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of liver disease. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype or attribute related to Diagnosis. The intent of this value set is to capture liver disease that would indicate that a statin medication may not be appropriate.),(Inclusion Criteria: Includes only relevant concepts associated with acute and chronic liver conditions that may represent the liver is failing. Examples of conditions include concepts associated with, but are not limited to, the following: alcoholic liver damage, cirrhosis, hepatitis C and E, and liver necrosis.),(Exclusion Criteria: Excludes hepatitis A and hepatitis B.)"
2.16.840.1.113762.1.4.1045.39,Low Dose Unfractionated Heparin for VTE Prophylaxis,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent unfractionated heparin medications with strengths that could reasonably be used for venous thromboembolism (VTE) prophylaxis. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low-dose unfractionated heparin as VTE prophylaxis.),(Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used to achieve a dose of at least 5000 units when administered subcutaneously.),(Exclusion Criteria: Excludes concentrations less than 250 units/mL.)"
2.16.840.1.113883.3.117.1.7.1.219,Low Molecular Weight Heparin for VTE Prophylaxis,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent low molecular weight heparin medications used for Venous Thromboembolism (VTE) prophylaxis. The medications included in this value set are administered parenterally. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low molecular weight heparin therapy as VTE prophylaxis. ),(Inclusion Criteria: Includes only relevant concepts associated with RxNorm codes that specifically represent low molecular weight heparins that are administered parenterally.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.400,Low Risk,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent results of an assessment or other measurement or observation that is ""low."" ),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to assessment. The intent of this data element is to identify patients who have an observation or measurement of an assessment that is ""low."" ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that specifically represent a qualifier value of ""low.""),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.107,Low intensity statin therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent low intensity statin medications as defined by the 2013 American College of Cardiology (ACC) and the American Heart Association (AHA) guideline.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with low intensity statin therapy medications.),(Exclusion Criteria: Excludes any other intensity of statin therapy.)"
2.16.840.1.113883.3.464.1003.117.12.1010,Lupus,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of lupus (lupus erythematosus).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for systemic, discoid, and drug-induced systemic lupus erythematosus. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1284,Macular Edema Findings Absent,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent macular edema is absent.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication, or could be used as a Diagnosis, or as an attribute to represent exam findings.),(Inclusion Criteria: Includes only relevant concepts associated with indicating the absence of macular edema.),(Exclusion Criteria: Concepts that indicate macular edema are excluded from this value set.)"
2.16.840.1.113883.3.526.3.1320,Macular Edema Findings Present,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the presence of macular edema.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication, or Diagnosis, or as an attribute to represent exam findings.),(Inclusion Criteria: Includes only relevant concepts associated with the presence of macular edema.),(Exclusion Criteria: Concepts that do not indicate macular edema are excluded from this value set.)"
2.16.840.1.113883.3.526.3.1251,Macular Exam,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent macular exam of the eye.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study.),(Inclusion Criteria: Includes only relevant concepts associated with macular exams, where laterality is specified or not.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.105.12.1007,Major Depression,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent major depression.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis of major depression including mild, moderate, and severe depression; maternal depression; and depression with and without psychotic features. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes depression in remission.)"
2.16.840.113883.3.67.1.101.3.2444,Major Depression Including Remission,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses related to major depression, including types of depression and depression remission.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses for major depression. Chronic, recurrent, single episodes of depression are included, as are diagnoses from mild to severe. Depression remission is also included. This value set groups ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1491,Major Depressive Disorder-Active,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent major depressive disorders that are active.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with major depressive disorder diagnoses.),(Exclusion Criteria: Excludes major depressive disorders in remission.)"
2.16.840.1.113883.3.464.1003.199.12.1050,Malabsorption Syndromes,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of chronic intestinal malabsorption.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for regional enteritis, ulcerative enterocolitis, celiac disease, tropical sprue, blind loop syndrome, pancreatic steatorrhea, and other specified or unspecified intestinal malabsorption disorders. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes diagnoses of specified disorders of the intestine, including fistula of intestine, ulceration of intestine, perforation of intestine, angiodysplasia (with or without hemorrhage), dieulafoy lesion, and vomiting of fecal matter.)"
2.16.840.1.113883.3.560.100.1,Male,eCQM Update 2018-09-17,AdministrativeGender,HL7V3.0_2017-07,2.16.840.1.113883.5.1,"(Clinical Focus: This value set contains concepts that represent male.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Sex. ),(Inclusion Criteria: Includes only relevant concepts associated with appropriate male gender concepts.),(Exclusion Criteria: Excludes concepts representing female gender.)"
2.16.840.1.113883.3.464.1003.108.12.1001,Malignant Neoplasm of Colon,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent malignant neoplasms of the colon.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with indicating malignant neoplasms of the colon, rectum and anus. This is a grouping of ICD-10-CM, ICD-9-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.108.12.1009,Malignant Neoplasm of Lymphatic and Hematopoietic Tissue,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent lymphoma, leukemia and other malignant cancers of the lymphatic and hematologic systems.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses of lymphoma and other cancers of the lymph and hematologic systems.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.108.12.1018,Mammography,eCQM Update 2018-09-17,HCPCS,2017,2.16.840.1.113883.6.285,"(Clinical Focus: This value set contains concepts that represent mammography tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnostic Study, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with screening or diagnostic mammography. This is a grouping of HCPCS and LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1048,Marfan's Syndrome,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of Marfan's syndrome.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for Marfan's syndrome with or without cardiovascular, ocular, skeletal, or epithelial manifestations. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1053,Measles,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent measles infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with measles infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1059,Measles Antibody Test (IgG Antibody Titer),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests for the  titre (or amount) of IgG antibodies to measles.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with test codes for measles IgG antibody titres in the serum, or cerebrospinal fluid.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1060,Measles Antibody Test (IgG Antibody presence),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent test results related to IgG antibodies and measles. A positive test conveys immunologic protection against measles.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying positive antibody tests for measles IgG In the serum, cerebrospinal fluid or body fluid.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1224,"Measles, Mumps and Rubella (MMR) Vaccine",eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent measles, mumps and rubella (MMR) vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant measles, mumps and rubella (MMR) Vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1031,"Measles, Mumps and Rubella (MMR) Vaccine Administered",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures for measles, mumps and rubella (MMR) vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant measles, mumps and rubella (MMR) vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1506,Meclizine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent meclizine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; meclizine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; meclizine in combination with other medications.)"
2.16.840.1.113883.3.117.1.7.1.288,Medical Induction of Labor,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent procedures that represent the medical induction of labor.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify medical induction of labor. ),(Inclusion Criteria: Includes only relevant concepts associated with ICD-9-CM and SNOMED CT codes that identify the medical induction of labor.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1007,Medical Reason,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent medical reasons for when a patient does not receive a therapy or service.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Negation Rationale or Reason.),(Inclusion Criteria: Includes only relevant concepts associated with medically relevant reasons for not receiving a therapy or service.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.473,Medical Reason,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent situations that represent medical reasons for not providing treatment.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Negation Rationale or Reason. The intent of this data element is to identify medical reasons for not providing treatment. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing medical reasons for not providing treatment should be included.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.114222.4.1.214079.1.1.7,Medical Reasons,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent findings that indicate medical reasons for not conducting newborn hearing screening.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Negation Rationale. The intent of this data element is to identify patients who did not receive a newborn hearing screening due to a medical reason.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes to capture medical contraindication, surgical contraindication, or not indicated because there is a reason to withhold a certain medical procedure/treatment because it could harm a patient.),(Exclusion Criteria: Other reasons a screening was not performed, such as parent refusal, technical failure, or a missed procedure are excluded.)"
2.16.840.1.113883.3.600.1.1502,Medical or Other reason not done,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the reason not done.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Negation Rationale or Reason.),(Inclusion Criteria: Includes only relevant concepts associated with medical or other reason for procedure or treatment not done.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1834,Medications Encounter Code Set,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent multiple types of encounters that include documentation of current medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with identifying types of encounters associated with documentation of medications reviewed, updated or transcribed as the current medication list.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1342,Megestrol,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent megestrol medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; megestrol only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; megestrol in combination with other medications.)"
2.16.840.1.113883.3.464.1003.105.12.1004,Mental Health Diagnoses,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a mental health diagnoses.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Principal Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying mental health diagnoses.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1351,Meperidine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent meperidine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; meperidine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; meperidine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1284,Meprobamate,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent meprobamate medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; meprobamate only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; meprobamate in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1358,Metaxalone,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent metaxalone medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; metaxalone only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; metaxalone in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1370,Methocarbamol,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent methocarbamol medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; methocarbamol only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; methocarbamol in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1331,Methyldopa,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent methyldopa medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; methyldopa only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; methyldopa in combination with other medications.)"
2.16.840.1.113762.1.4.1110.25,Metroplasty,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent repair of the uterus procedures performed by any approach.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this value set is to identify patients who have had a metroplasty, uteroplasty, hysteroplasty, or repair of the uterus procedure.),(Inclusion Criteria: Includes only relevant concepts associated with metroplasty, uteroplasty, hysteroplasty, and repair of uterus procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.98,Moderate intensity statin therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent moderate intensity statin medications as defined by the 2013 American College of Cardiology (ACC) and the American Heart Association (AHA) guideline.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with moderate intensity statin therapy medications.),(Exclusion Criteria: Excludes any other intensity of statin therapy.)"
2.16.840.1.113883.3.526.3.1092,Moderate or Severe,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent severe and moderate levels of severity.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Severity. ),(Inclusion Criteria: Includes only relevant concepts associated with specific to severe and moderate levels of severity.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1464,"Moderate or Severe Impairment, Better Eye, Profound Impairment Lesser Eye",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of moderate or severe impairment in one eye with profound impairment in the other eye.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of blindness in one eye of categories 3, 4 or 5 with low vision in the other eye of categories 1 or 2.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1090,Moderate or Severe LVSD,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of moderate or severe left ventricular systolic dysfunction (LVSD). ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of moderate or severe LVSD.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.823,Moderation of ETOH Consumption Recommendation,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the type of interventions relevant to alcohol use.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure or Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with indicating the type of education provided, referral to community service or rehabilitation center for alcohol use.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1558,Morgagnian Cataract,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent morgagnian cataract.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with morgagnian cataract.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.110.12.1032,Mumps,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent mumps infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with mumps infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1061,Mumps Antibody Test (IgG Antibody Titer),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent test results for titre (amount) of mumps IgG antibody.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying titres for mumps antibody IgG in serum and by immunofluorescence in cerebrospinal fluid or serum.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1062,Mumps Antibody Test (IgG Antibody presence),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent test results for presence of mumps IgG antibody.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying positive antibody tests for mumps IgG.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.403,Myocardial Infarction,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of myocardial infarction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of myocardial infarction.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.422,Myomectomy,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent myomectomy procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify a myomectomy.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify a myomectomy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.114.12.1011,Narcolepsy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of narcolepsy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes to identify narcolepsy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.2451,Negative Depression Screening,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent situations in which a depression screen was performed by the health care professional and the finding was negative for depression.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment. ),(Inclusion Criteria: Includes only relevant concepts associated with screening for depression whereby the outcome is negative.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.195.12.1002,Negative Finding,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a negative finding. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Result. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying a negative finding for an exam.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.75,Neonatal Intensive Care Unit (NICU),eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a neonatal intensive care unit (NICU) location.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Location. The intent of this data element is to identify the NICU. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify the NICU.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.114222.4.1.214079.1.1.3,Newborn Hearing Screen Left,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent procedures or evaluations for newborn hearing screening conducted on left ear.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnostic Study, Performed. The intent of this data element is to identify patients who have received newborn hearing screening of the left ear.),(Inclusion Criteria: Includes only relevant concepts associated with LOINC code for newborn hearing screen of the left ear.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.114222.4.1.214079.1.1.4,Newborn Hearing Screen Right,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent procedures or evaluations for newborn hearing screening conducted on right ear. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnostic Study, Performed. The intent of this data element is to identify patients who have received newborn hearing screening of the right ear.),(Inclusion Criteria: Includes only relevant concepts associated with LOINC codes for newborn hearing screen of the right ear.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1353,Nifedipine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent nifedipine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; nifedipine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; nifedipine in combination with other medications.)"
2.16.840.1.113883.3.117.1.7.1.424,Non-Elective Inpatient Encounter,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures for non-elective inpatient encounters.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify non-elective inpatient encounters. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing non-elective inpatient encounters.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1480,Nonbenzodiazepine hypnotics,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent nonbenzodiazepine hypnotic medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; nonbenzodiazepine hypnotic medications.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; benzodiazepine derivative medications.)"
2.16.840.1.113883.3.464.1003.196.12.1507,Nortriptyline,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent nortriptyline medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; nortriptyline only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; nortriptyline in combination with other medications.)"
2.16.840.1.113883.3.464.1003.101.12.1012,Nursing Facility Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an interaction with a member of their medical team on admission to a nursing facility.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with services provided to new and established patients in a nursing facility (skilled, intermediate and long-term care facilities).),(Exclusion Criteria: Excludes visits in settings other than a nursing facility.)"
2.16.840.1.113883.3.526.3.1465,Nystagmus and Other Irregular Eye Movements,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of nystagmus and other irregular eye movements.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of nystagmus.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113762.1.4.1,ONC Administrative Sex,eCQM Update 2018-09-17,AdministrativeGender,HL7V3.0_2017-07,2.16.840.1.113883.5.1,"(Clinical Focus: This value set contains concepts that represent gender identity restricted to only male and female used in administrative situations requiring a restriction to these two categories.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Sex. ),(Inclusion Criteria: Includes relevant concepts associated with gender concepts for male and female only.),(Exclusion Criteria: Excludes any gender identity that is not male or female.)"
2.16.840.1.113762.1.4.1111.143,Observation Services,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent observation encounter types.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have had an observation encounter. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing inpatient encounter.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.263,Obstetrics,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set grouping contains concepts that represent a condition, problem, or diagnosis related to pregnancy or obstetrics.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. The intent of this data element is to identify patients who have a condition, problem or diagnosis related to pregnancy or obstetrics.),(Inclusion Criteria: Includes only relevant concepts associated with a condition, problem or diagnosis related to pregnancy or obstetrics.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.264,Obstetrics VTE,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a venous thromboembolism related to pregnancy or obstetrics.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have a venous thromboembolism related to pregnancy or obstetrics.),(Inclusion Criteria: Includes only relevant concepts associated with a venous thromboembolism related to pregnancy or obstetrics.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1011,Occupational Therapy Evaluation,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits for evaluations for occupational therapy services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with applicable codes for occupational therapy evaluations.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.11.1005,Office Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an office or other outpatient visit.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity. This is an extensional value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.12.1001,Office Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an office or other outpatient visit.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity. This is a grouping value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.526.3.1430,Open Wound of Eyeball,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of open wound of the eyeball.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of choroidal rupture, traumatic enucleation of eye, and avulsion, contusion, laceration, penetration and/or rupture of eye.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.101.11.1206,Ophthalmologic Outpatient Visit,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent ophthalmological visits.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with relevant encounters during which the patient sees an eye care professional.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1285,Ophthalmological Services,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent ophthalmological visits.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with encounters during which the patient sees an eye care professional.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1466,Optic Atrophy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of optic atrophy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of optic atrophy, which may include atrophy of the optic disc.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1334,Optic Disc Exam for Structural Abnormalities,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent studies specific to looking for structural abnormalities of the optic disc by ophthalmoscopy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study.),(Inclusion Criteria: Includes only relevant concepts associated with studies using ophthalmoscopy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1467,Optic Neuritis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of optic neuritis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of optic neuritis, neuropathy, neuroretinitis, and papillitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.117.1.7.1.134,Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent oral factor Xa inhibitors indicated for venous thromboembolism (VTE) prophylaxis and treatment. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive oral factor Xa inhibitors for VTE prophylaxis. ),(Inclusion Criteria: Includes only relevant concepts associated with oral forms of factor Xa inhibitors.),(Exclusion Criteria: Excludes other dose forms of factor Xa inhibitors.)"
2.16.840.1.113883.3.464.1003.113.12.1044,Osteogenesis Imperfecta,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of osteogenesis imperfecta.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for osteogenesis imperfecta disease classifications 1-4. Includes only relevant concepts associated with diagnoses in perinatal population. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes diagnosis of osteoporosis with pseudoglioma.)"
2.16.840.1.113883.3.464.1003.113.12.1049,Osteopenia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of osteopenia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for specified and unspecified disorders of bones and cartilage. Includes only relevant concepts associated with osteopenia of prematurity, drug-induced osteopenia, and senile osteopenia. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes diagnosis of arrest of bone development or growth, chondromalacia, or stress fracture of bone.)"
2.16.840.1.113883.3.464.1003.113.12.1038,Osteoporosis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of osteoporosis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for idiopathic, senile, disuse, and other/unspecified osteoporosis. Includes only relevant concepts associated with localized, transient, and regional migrating osteoporosis. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes diagnosis codes for osteoporosis due to cystic fibrosis.)"
2.16.840.1.113883.3.464.1003.113.12.1050,Osteoporotic Fractures,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent codes that are used to identify patients with a diagnosis of osteoporotic fracture.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes associated with osteoporotic fracture. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1469,Other Background Retinopathy and Retinal Vascular Changes,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other background retinopathy and retinal vascular changes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of various retinal changes and retinopathies, including exudative retinopathy, retinal neovascularization, arteriolitis, arteritis, endarteritis, phlebitis, and vasculitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1470,Other Corneal Deformities,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other corneal deformities.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of corneal deformities, including corneal ectasia, staphyloma, degenerations, and descemetocele.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1471,Other Disorders of Optic Nerve,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other disorders of optic nerve.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of ischemic optic neuropathy.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1472,Other Disorders of Sclera,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other disorders of sclera.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of staphyloma posticum or scleral ectasia.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1473,Other Endophthalmitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other endophthalmitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of ophthalmia nodosa, parasitic cyst or endophthalmitis, panuveitis, sympathetic uveitis, or other endophthalmitis diagnoses.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.111.12.1006,Other Female Reproductive Conditions,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent female reproductive conditions that may be related to sexual activity.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a variety of reproductive conditions that may indicate sexual activity. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes for other reproductive conditions that could indicate sexual activity but that are already described in other value sets.)"
2.16.840.1.113883.3.526.3.1480,Other Proliferative Retinopathy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other proliferative retinopathy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of premature retinopathy.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1474,Other Retinal Disorders,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other retinal disorders.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with various retinal disorders, which includes retinal deposits, flecking, hemorrhage, edema, and ischemia.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.109.12.1015,Other Services Related to Dialysis,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent services related to dialysis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Intervention, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with other services related to dialysis.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1468,Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of other and unspecified forms of chorioretinitis and retinochoroiditis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of posterior cyclitis, chorioretinal inflammation, other chorioretinitis or retinitis or retinochoroiditis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.101.11.1040,Outpatient Consultation,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an outpatient interaction at an office with a member of their medical care team.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity. This is an extensional value set of CPT and SNOMED CT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.12.1008,Outpatient Consultation,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an outpatient interaction at an office with a member of their medical care team.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity. This is a grouping value set of CPT and SNOMED CT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113762.1.4.1047.9,Outpatient Encounters for Preventive Care,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent outpatient encounters.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with evaluation and management of a new or established patient through an encounter for annual visit, preventative evaluation, follow-up, or periodic re-evaluations that would occur in the outpatient setting.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.502,Overweight or Obese,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent overweight or obese patients.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis or Finding.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who are currently overweight or obese.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1045.55,Oxytocin,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medications that represent oxytocin.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify medications that represent oxytocin. ),(Inclusion Criteria: Includes only relevant concepts associated with RxNorm codes that identify medications that represent oxytocin as a single ingredient, administered in an injectable form.),(Exclusion Criteria: Excludes drugs that have multiple ingredients. In addition, drugs with dose forms not consistent with injectable administration should not be included. The codes should be limited to those which are for human use and which are able to be prescribed in the US.)"
2.16.840.1.113762.1.4.1045.67,PCI,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent procedures used to define percutaneous coronary intervention (PCI).),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed. The intent of this data element is to identify patients who had percutaneous coronary intervention (PCI) during an episode of acute myocardial infarction. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients receiving percutaneous coronary intervention (PCI). This is a grouping of ICD-10-PCS and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1138,PROMIS 10 Global Mental Health Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 10 Global Mental Health Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 10 Global Mental Health Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1139,PROMIS 10 Global Physical Health Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 10 Global Physical Health Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 10 Global Physical Health Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1216,PROMIS 29 Anxiety Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 29 Anxiety Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 29 Anxiety Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1215,PROMIS 29 Depression Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 29 Depression Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 29 Depression Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1214,PROMIS 29 Fatigue Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 29 Fatigue Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 29 Fatigue Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1213,PROMIS 29 Pain Interference Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 29 Pain Interference Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 29 Pain Interference Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1212,PROMIS 29 Physical Function Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 29 Physical Function Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 29 Physical Function Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1211,PROMIS 29 Sleep Disturbance Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 29 Sleep Disturbance Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 29 Sleep Disturbance Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1217,PROMIS 29 Social Roles Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the PROMIS 29 Satisfaction with Social Roles Score. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the PROMIS 29 Satisfaction with Social Roles Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.451,Pain Related to Prostate Cancer,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent pain associated with prostate cancer.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with pain related to prostate cancer.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1579,Palliative Care,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent identifying patients receiving palliative, comfort or hospice care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients receiving palliative, comfort or hospice care.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1575,Palliative care encounter,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent identifying patients receiving palliative, comfort or hospice care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients receiving palliative, comfort or hospice care.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.108.12.1017,Pap Test,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent identify cervical cytology tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Order or Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with cervical cytology tests. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes cytology performed on non-cervical samples. Excludes codes that indicate that this test was ordered only, and not necessarily performed.)"
2.16.840.1.113883.3.117.1.7.1.38,Parenteral Nutrition,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent parenteral infusion procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify parenteral infusion procedures. ),(Inclusion Criteria: Includes only relevant concepts associated with ICD-10-PCS and SNOMED CT codes that identify parenteral infusion.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113883.3.464.1003.196.12.1508,Paroxetine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent paroxetine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; paroxetine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; paroxetine in combination with other medications.)"
2.16.840.1.114222.4.1.214079.1.1.6,Pass Or Refer,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent findings that indicate the normal findings on hearing examination or referral is needed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Result. The intent of this data element is to identify patients who received a newborn hearing screening with result of pass or refer.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing concepts associated with normal finding on hearing examination and referral.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1432,Pathologic Myopia,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of pathologic myopia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of degenerative disorders of eye, Forster-Fuchs' spot, malignant or severe myopia, and myopic macular degeneration.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.117.1.7.1.309,Patient Expired,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a patient who has died in the hospital.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Discharge Disposition. The intent of this data element is to identify the discharge status of patient expired as an attribute of the inpatient encounter. ),(Inclusion Criteria: Includes only relevant concepts associated with codes for a patient who had died in the hospital. Codes used are to be SNOMED CT codes only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1012,Patient Provider Interaction,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent provider interactions with patients that include both face-to-face and virtual types of encounters.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with provider interactions with patients that are conducted in an office or care setting, as well as interactions which may occur via virtual methods, such as telephone calls, emails, and letters.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1008,Patient Reason,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent patient-specific reasons for when a patient does not receive a therapy or service.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Reason. ),(Inclusion Criteria: Includes only relevant concepts associated with patient-specific reasons for not receiving a therapy or service.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1140,Patient Reason for ACE Inhibitor or ARB Decline,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a patient reason for declining angiotensin-converting enzyme (ACE) inhibitor or angiotensin ii receptor blocker (ARB) therapy. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication, or may be used as an attribute.),(Inclusion Criteria: Includes only relevant concepts associated with patient reason declining ACE inhibitor or ARB therapy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.791,Patient Reason refused,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a reason for patient refusal.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Negation Rationale.),(Inclusion Criteria: Includes only relevant concepts associated with identifying a patient's reason for refusing treatment.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.93,Patient Refusal,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent situations representing a patient's refusal for treatment.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Reason. The intent of this data element is to identify reasons a patient refuses treatment.),(Inclusion Criteria: Includes only relevant concepts associated with identifying refusal of any intervention (including procedures, treatment, medication, counseling, screening).​),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1009,Patient not ambulatory,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent patients who are not ambulatory.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with lack of mobility such as confined to chair or bed, and unable to walk or does not initiate walking. Concepts include wheelchair bound patients, independent in wheel chair as well as dependent on helper pushing wheelchair. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: Excludes codes that indicate that patient is ambulatory.)"
2.16.840.1.114222.4.11.3591,Payer,eCQM Update 2018-09-17,SOP,8.0,2.16.840.1.113883.3.221.5,"(Clinical Focus: This value set contains concepts that represent categories of types of health care payor entities as defined by the US Public Health Data Consortium SOP code system.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Payer.
),(Inclusion Criteria: Includes only relevant concepts associated with payer codes in the code system.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.104.12.1010,Percutaneous Coronary Interventions,eCQM Update 2018-09-17,CPT,2012,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have undergone percutaneous coronary intervention.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with codes to identify percutaneous coronary interventions.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1110.14,Perforation of Uterus,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses that represent perforation of the uterus.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. The intent of this data element is to identify perforation of the uterus.),(Inclusion Criteria: Includes only relevant concepts associated with identifying perforation of the uterus.),(Exclusion Criteria: Excludes codes identifying perforation to body structures other than the uterus.)"
2.16.840.1.113883.3.526.3.1084,Peritoneal Dialysis,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent the administration of peritoneal dialysis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with the administration of peritoneal dialysis.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.67.1.101.1.246,Personality Disorder,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses related to personality disorder. These specific diagnoses incorporate disorders in which the patient could not reliably complete a PHQ-9 tool due to their condition.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses for personality disorder, including borderline, cyclothymic, histrionic, and factitious disorders. This is grouping SNOMED CT, ICD-9-CM and ICD-10-CM codes.),(Exclusion Criteria: Excludes some personality disorders. Does not include ALL personality disorders (e.g., does not include narcissistic or obsessive compulsive personality disorders).)"
2.16.840.1.113883.3.464.1003.105.12.1152,Pervasive Developmental Disorder,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of autistic disorder, other childhood disintegrative disorder or other pervasive developmental disorder.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients with a diagnosis of autistic disorder, other childhood disintegrative disorder or other pervasive developmental disorder. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT concepts.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1348,Phenobarbital,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent phenobarbital medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; phenobarbital only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; Phenobarbital in combination with other medications.)"
2.16.840.1.113883.3.600.1518,Physical Activity Recommendation,eCQM Update 2018-09-17,HCPCS,2018,2.16.840.1.113883.6.285,"(Clinical Focus: This value set contains concepts that represent exercise, education and nutrition.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with promoting exercise and nutrition regimens.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1221,Pneumococcal Conjugate Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent pneumococcal vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all pneumococcal vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1046,Pneumococcal Conjugate Vaccine Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedure codes for pneumococcal vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all pneumococcal vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1027,Pneumococcal Vaccine,eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent conjugate and polysaccharide pneumococcal vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable. Includes only relevant concepts associated with the pneumococcal conjugate 13-valent and the pneumococcal polysaccharide 23-valent vaccine. This is a grouping of CVX codes.),(Exclusion Criteria: Excludes codes that represent the pneumococcal conjugate 7-valent vaccine.)"
2.16.840.1.113883.3.464.1003.110.12.1034,Pneumococcal Vaccine Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent administration of pneumococcal vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with administration of the pneumococcal vaccine. This is a grouping of CVX and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1076,Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent Pneumocystis jiroveci pneumonia (PCP) prophylaxis medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Order.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable. Includes only relevant concepts associated with trimethoprim-sulfamethoxazole, dapsone, atovaquone, and pentamidine isethionate.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; PCP prophylaxis medications in combination with other medications.)"
2.16.840.1.113883.3.600.2450,Positive Depression Screening,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent situations in which a depression screen was performed by the health care professional and the finding or result was positive for depression.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment.),(Inclusion Criteria: Includes only relevant concepts associated with screening for depression whereby the outcome is positive.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.121.12.1016,Positive Finding,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent positive test results. This is intended to be paired with other concepts that identify specific medical tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Result. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying a positive test result.),(Exclusion Criteria: Excludes concepts that identify a specific type of medical test.)"
2.16.840.1.113883.3.526.3.1433,Posterior Lenticonus,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of posterior lenticonus.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of posterior lenticonus, including spherophakia.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.378,Pregnancy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent the presence of pregnancy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria:  Includes only relevant concepts associated with the presence of pregnancy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1623,Pregnancy Dx,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses and disorders that indicate pregnancy, type of pregnancy and termination of pregnancy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attributes related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who were pregnant, termination of pregnancy and type of pregnancy.),(Exclusion Criteria: Excludes previously conceived and past delivered pregnancies.)"
2.16.840.1.113883.3.464.1003.111.12.1011,Pregnancy Test,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent urine, serum, or plasma pregnancy tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Order.),(Inclusion Criteria: Includes only relevant concepts associated with conducting a pregnancy test. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.379,Prescribed Medications Education,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to represent patients who receive prescribed medications education.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication. The intent of this data element is to identify patients who receive education on the medications they were prescribed to take.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing prescribed medications education.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.11.1120,"Preventive Care - Established Office Visit, 0 to 17",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an office or other outpatient visit for preventive care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity. This is an extensional value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.11.1110,"Preventive Care - Initial Office Visit, 0 to 17",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have had an office or other outpatient visit for preventive care.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity. This is an extensional value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.12.1025,"Preventive Care Services - Established Office Visit, 18 and Up",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients over the age of 18 who have had an established preventive care office visit.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive preventive medicine reevaluation and management of an individual over the age of 18. This is a grouping value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.11.1125,"Preventive Care Services - Established Office Visit, 18 and Up",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients over the age of 18 who have had an established preventive care office visit.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive preventive medicine reevaluation and management of an individual over the age of 18. This is an extensional value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.12.1027,Preventive Care Services - Group Counseling,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent group counseling services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying preventive medicine counseling and/or risk factor reduction intervention(s) provided to individuals in a group setting.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1030,Preventive Care Services - Other,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent unlisted preventive medicine services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with unlisted preventive medicine services. This is a grouping of a CPT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1022,"Preventive Care Services, Initial Office Visit, 0 to 17",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent initial comprehensive preventive medical evaluation, including regular preventive care or care of small problem or preexisting condition that requires no extra work, to be associated with patients 0-17 years of age, that have no prior outpatient professional services from the physician practice in the last 3 years.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with ages 0-17, and that indicate initial comprehensive preventive medical evaluation, including regular preventive care or care of small problem or preexisting condition that requires no extra work, for a patient that has no prior outpatient professional services from the physician practice in the last 3 years. This is a grouping value set of CPT codes.),(Exclusion Criteria: Excludes codes that are not for comprehensive preventive medical evaluations and codes that are for patients who have been seen in the last 3 years.)"
2.16.840.1.113883.3.464.1003.101.12.1026,Preventive Care Services-Individual Counseling,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients who have received preventive medicine counseling and/or risk factor reduction interventions.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with counseling, anticipatory guidance, and risk factor reduction interventions. Preventative care and individual counseling encounters can be 15 to 60 minutes. This is a grouping of CPT codes.),(Exclusion Criteria: Excludes codes for services performed in the emergency department, including critical care and observation services.)"
2.16.840.1.113883.3.464.1003.101.12.1023,"Preventive Care Services-Initial Office Visit, 18 and Up",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients over the age of 18 who have had an initial preventive care office visit.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive preventive medicine reevaluation and management of an individual over the age of 18. This is a grouping value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.11.1115,"Preventive Care Services-Initial Office Visit, 18 and Up",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent patients over the age of 18 who have had an initial preventive care office visit.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with comprehensive preventive medicine reevaluation and management of an individual over the age of 18. This is an extensional value set of CPT codes.),(Exclusion Criteria: Excludes non-office visits, including telehealth services.)"
2.16.840.1.113883.3.464.1003.101.12.1024,"Preventive Care, Established Office Visit, 0 to 17",eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent initial comprehensive preventive medical evaluation, including regular preventive care or care of small problem or preexisting condition that requires no extra work, to be associated with patients 0-17 years of age, that received prior outpatient professional services from the physician practice in the last 3 years.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with ages 0-17, and indicating initial comprehensive preventive medical evaluation, including regular preventive care or care of small problem or preexisting condition that requires no extra work, for a patient that received prior outpatient professional services from the physician practice in the last 3 years. This is a grouping value set of CPT codes.),(Exclusion Criteria: Excludes codes that are not for comprehensive preventive medical evaluations and codes that are for patients who have not been seen in the last 3 years.)"
2.16.840.1.113883.3.526.3.1185,Previous Receipt of Influenza Vaccine,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a patient reporting a previous receipt of an influenza vaccine.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication or Assessment.),(Inclusion Criteria: Includes only relevant concepts associated with a patient reporting a previous receipt of an influenza vaccine.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.326,Primary Open-Angle Glaucoma,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of primary open-angle glaucoma (POAG).),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of primary open-angle glaucoma (POAG).),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.198.12.1006,Primary THA Procedure,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent primary Total Hip Arthroplasty (THA) procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with codes that identify primary THA procedures. This is a grouping of CPT, HCPCS and SNOMED CT codes.),(Exclusion Criteria: Excludes codes for revision or partial hip arthroplasty procedures.)"
2.16.840.1.113883.3.464.1003.198.12.1007,Primary TKA Procedure,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent primary Total Knee Arthroplasty (TKA) procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with codes that identify primary TKA procedures. This is a grouping of CPT, HCPCS and SNOMED CT codes.),(Exclusion Criteria: Excludes codes for revision or partial knee arthroplasty procedures.)"
2.16.840.1.113883.3.117.1.7.1.14,Principal,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the qualifier value used to identify the term principal.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Ordinality.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that define the principal qualifier value.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113883.3.526.3.1434,Prior Pars Plana Vitrectomy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent pars plana vitrectomy procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with a vitrectomy using the pars plana approach.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1475,Prior Penetrating Keratoplasty,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of penetrating keratoplasty.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of keratoconus.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.111.12.1009,Procedures During Pregnancy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures conducted during pregnancy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with procedures conducted on a patient during pregnancy. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.111.12.1010,Procedures Involving Contraceptive Devices,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures involving contraceptive devices.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with procedures related to contraceptive devices. This is a grouping of CPT, HCPCS and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1476,"Profound Impairment, Both Eyes",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of profound impairment of both eyes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of blindness in both eyes, which Includes blindness categories 3, 4 or 5.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.196.12.1367,Promethazine Hydrochloride,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent promethazine hydrochloride medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; promethazine hydrochloride only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; promethazine hydrochloride in combination with other medications.)"
2.16.840.1.113883.3.526.3.319,Prostate Cancer,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent prostate cancer diagnosis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with prostate cancer diagnoses.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.398,Prostate Cancer Treatment,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent prostate cancer treatments.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with interstitial prostate brachytherapy, external beam radiotherapy to the prostate and radical prostatectomy.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.401,Prostate Specific Antigen Test,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent prostate specific antigen (PSA) test.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Laboratory Test.),(Inclusion Criteria: Includes only relevant concepts associated with prostate specific antigen (PSA) tests.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1003,Proteinuria,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of proteinuria.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of proteinuria.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1509,Protriptyline,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent protriptyline medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; protriptyline only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; protriptyline in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1345,Pseudoephedrine / Triprolidine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent pseudoephedrine / triprolidine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; pseudoephedrine / triprolidine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; pseudoephedrine / triprolidine in combination with other medications.)"
2.16.840.1.113883.3.526.3.1435,Pseudoexfoliation Syndrome,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of pseudoexfoliation syndrome.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of pseudoexfoliation of lens or pseudoexfoliation glaucoma.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.113.12.1046,Psoriatic Arthritis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of psoriatic arthritis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with psoriatic arthritis, arthritis mutilans, psoriatic spondylitis, and other unspecified psoriatic arthropathy. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes diagnosis codes for juvenile psoriatic arthritis and dactylitis.)"
2.16.840.1.113883.3.526.3.1492,Psych Visit - Diagnostic Evaluation,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits during which a psychiatric diagnostic evaluation is completed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with visits with the completion of psychiatric diagnostic evaluations.),(Exclusion Criteria: Excludes group psychotherapy or family psychotherapy.)"
2.16.840.1.113883.3.526.3.1018,Psych Visit - Family Psychotherapy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits during which family psychotherapy is performed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with family psychotherapy.),(Exclusion Criteria: Excludes group psychotherapy or individual psychotherapy visits.)"
2.16.840.1.113883.3.526.3.1496,Psych Visit - Psychotherapy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits for psychotherapy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with visits for individual psychotherapy services.),(Exclusion Criteria: Excludes group psychotherapy or family psychotherapy.)"
2.16.840.1.113883.3.117.1.7.1.299,Psychiatric/Mental Health Diagnosis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set grouping contains concepts that represent diagnoses commonly used in the inpatient setting for psychiatric and mental health disorders.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attributes related to Diagnosis. The intent of this data element is to identify patients who have an active diagnosis of a psychiatric or mental health disorder.),(Inclusion Criteria: Includes only relevant concepts associated with representing an active diagnosis for psychiatric and mental health disorders using ICD-10-CM and SNOMED CT codes systems.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1141,Psychoanalysis,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits for psychoanalysis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with psychoanalysis.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1055,Psychotherapy and Pharmacologic Management,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent psychotherapy services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying psychotherapy services.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1477,Purulent Endophthalmitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of purulent endophthalmitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of purulent endophthalmitis, panophthalmitis, vitreous abscess, and other types of endophthalmitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.114222.4.11.836,Race,eCQM Update 2018-09-17,CDCREC,1.2,2.16.840.1.113883.6.238,"(Clinical Focus: This value set contains concepts that represent the general race category reported by the patient - subject may have more than one; defined by the Centers for Disease Control and Prevention and National Center for Health Statistics.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Race.),(Inclusion Criteria: Includes only relevant concepts associated with the following race categories: American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, Other Race, White.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1026,Radiation Treatment Management,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent radiation treatment management.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with radiation treatment management.),(Exclusion Criteria:  No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1046,Referral,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a referral for a patient to a practitioner for evaluation, treatment or co-management of a patient's condition.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with referrals and consultations.),(Exclusion Criteria: Excludes self referrals.)"
2.16.840.1.113883.3.600.537,Referral for Depression Adolescent,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent appropriate referrals specific to the child and adolescent age group for depression management.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with appropriate referrals as specific to the child and adolescent age group for depression management.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.538,Referral for Depression Adult,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent appropriate referrals specific to the adult age group for depression management.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with appropriate referrals as specific to the adult age group for depression management.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1475,Referral to Alternative Provider / Primary Care Provider,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the types of referrals made by the alternate or primary care provider.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with the different types of services and providers.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.1.1527,Referrals where weight assessment may occur,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent multiple types of providers and settings for weight assessment.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention or Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with multiple providers in different settings performing weight assessments.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1045.18,Rehabilitation Assessment,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures that represent rehabilitation assessment of patients post stroke.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify assessments for rehabilitation assessment following a stroke.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify a rehabilitation assessment procedures post stroke.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113762.1.4.1045.19,Rehabilitation Therapy,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures that represent rehabilitation therapy post stroke.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify stroke rehabilitation therapies.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify rehabilitation therapies used appropriate for stroke rehabilitation.),(Exclusion Criteria: Excludes codes that do not meet the inclusion criteria.)"
2.16.840.1.113883.3.526.3.1436,Removal Procedures,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent removal procedures of the eye.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with removal procedures of the eye, including removal of foreign body, implanted material, etc.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1151,Renal Failure Due to ACE Inhibitor,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of renal failure due to Angiotensin converting enzyme (ACE) inhibitor. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of renal failure due to ACE inhibitor.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1478,Retinal Detachment with Retinal Defect,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of retinal detachment with a retinal defect.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of various types of retinal detachments.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1437,Retinal Repair Procedures,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent retinal repair procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with procedures for repairing the retina, including reattachment, scleroplasty and repositioning.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1479,Retinal Vascular Occlusion,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of retinal vascular occlusion.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of retinal vein or artery occlusion.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.115.12.1088,Retinal or Dilated Eye Exam,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent patients who have received a retinal or dilated eye exam.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Physical Exam, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with procedural codes that indicate a retinal and dilated eye exam took place.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1438,Retrolental Fibroplasias,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of retrolental fibroplasias.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of retrolental fibroplasias, including retinopathy of prematurity.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1439,Revision Procedures,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent revision procedures of the eye.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with revision or repair procedures of the eye.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.102,Rhabdomyolysis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis or condition of rhabdomyolysis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with the diagnosis of rhabdomyolysis.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1005,Rheumatoid Arthritis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of rheumatoid arthritis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with rheumatoid arthritis and Felty's syndrome. Includes only relevant concepts associated with comorbidities occurring with rheumatoid arthritis, such as rheumatoid polyneuropathy, rheumatoid myopathy, rheumatoid heart disease, rheumatoid vasculitis, and rheumatoid lung disease. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes codes for juvenile chronic polyarthritis, chronic post rheumatic arthropathy, and inflammatory polyarthropathy.)"
2.16.840.1.113883.3.464.1003.122.12.1035,Right,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the right side of the body.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Anatomical Location Site.),(Inclusion Criteria: Includes only relevant concepts associated with the right side of the body. This is a grouping of SNOMED CT codes.),(Exclusion Criteria: Excludes concepts representing the left side of the body.)"
2.16.840.1.113883.3.464.1003.113.12.1057,Right Unilateral Amputation Above or Below Knee,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent right unilateral amputation above or below the knee procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying right unilateral amputations above or below the knee.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.113.12.1073,Right Unilateral Amputation Procedure Above or Below Knee,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent right unilateral amputation above or below the knee procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who have had a right unilateral amputation procedure above or below the knee.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.380,Risk Factors Education,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to represent patients who receive risk factor education.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication. The intent of this data element is to identify patients who receive education on risk factors. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing risk factor education.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1223,Rotavirus Vaccine (3 dose schedule),eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent rotavirus (3-dose schedule) vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all rotavirus (3-dose schedule) vaccine codes. This is a grouping of CVX codes. ),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1037,Rubella,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent rubella infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with all associated rubella infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1063,Rubella Antibody Test (IgG Antibody Titer),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests for the titre (amount) of rubella IgG antibody in serum.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with testing to identify titres for rubella IgG antibody.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1064,Rubella Antibody Test (IgG Antibody presence),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests for the presence of rubella IgG antibody in serum.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with testing the presence of rubella IgG antibody.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.399,Salvage Therapy,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent salvage therapy procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with salvage therapy procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.105.12.1104,Schizophrenia or Psychotic Disorder,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of all types of schizophrenia and schizoaffective disorders.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying all types of schizophrenia and schizoaffective disorders. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT concepts.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1440,Scleral Procedures,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent scleral procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with scleral reinforcement procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1481,Scleritis and Episcleritis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of scleritis and episcleritis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of specific types of scleritis or episcleritis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1482,Separation of Retinal Layers,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of separation of the layers of the retina.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of serous chorioretinopathy and types of retinal detachment.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.120.12.1007,Severe Combined Immunodeficiency,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses that indicate a severe combined immunodeficiency including both genetic and other causes.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnoses that indicate the presence of a severe combined immunodeficiency including genetic conditions.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1025,Severe Dementia,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a diagnosis of severe dementia.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of severe dementia.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.121.12.1040,Sexually Active,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent vaginal intercourse.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with concepts that indicate whether a patient has had vaginal intercourse.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.26,Single Live Born Newborn Born in Hospital,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent types of delivery that represent the single live birth.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying single live born newborn.),(Exclusion Criteria: Excludes codes indicating the birth took place outside of the hospital.)"
2.16.840.1.113883.3.526.3.1530,Speech and Hearing Evaluation,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent visits for speech and hearing evaluation.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.),(Inclusion Criteria: Includes only relevant concepts associated with evaluation of speech and/or hearing related abilities.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1047.47,Stable and Unstable Angina,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent the diagnosis of angina.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with stable and unstable angina, pre and post infarction angina, angina decubitus, intermediate coronary syndrome, other unspecified angina or sequelae of myocardial infarction, and other forms of angina pectoris.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1028,Standardized Pain Assessment Tool,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent pain assessment tools or instruments used to quantify pain intensity.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment.),(Inclusion Criteria: Includes only relevant concepts associated with pain assessment tools or instruments used to quantify pain intensity such as 0-10 numerical rating scale, visual analog scale, a categorical scale, pictorial scale, faces pain rating scale, or the Brief Pain Inventory (BPI).),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1006,Standardized Tools for Assessment of Cognition,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the total score results for the standardized tools used for the assessment of cognition.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment.),(Inclusion Criteria: Includes only relevant concepts associated with total score results for the following standardized tools:
-Blessed Orientation-Memory-Concentration Test (BOMC)
-Montreal Cognitive Assessment (MoCA)
-St. Louis University Mental Status Examination (SLUMS)
-Mini-Mental State Examination (MMSE) [Note: The MMSE has not been well validated for non-Alzheimer's dementias]
-Short Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
-Ascertain Dementia 8 (AD8) Questionnaire
-Minimum Data Set (MDS) Brief Interview of Mental Status (BIMS) [Note: Validated for use with nursing home patients only]
-Formal neuropsychological evaluation
-Mini-Cog.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.423,Statin Allergen,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent an allergy to statin medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Allergy/Intolerance. Statin allergens as structured in RxNorm.),(Inclusion Criteria: Includes only relevant concepts associated with codes that use the IN term type for statins.),(Exclusion Criteria: Excludes non-statin medications.)"
2.16.840.1.113762.1.4.1110.19,Statin Grouper,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent statin medications that are prescribed for therapy at hospital discharge.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed statin medications at discharge.),(Inclusion Criteria: Includes only relevant concepts associated with single and multiple ingredient prescribable statin medications. Oral dose forms should be included. Generic only.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1069,Status Post Left Mastectomy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a history of a left mastectomy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with patients that have a history of a left mastectomy. This is a grouping of SNOMED CT and ICD-10-CM codes.),(Exclusion Criteria: Excludes codes that indicate a right or bilateral mastectomy or are unspecified.)"
2.16.840.1.113883.3.464.1003.198.12.1070,Status Post Right Mastectomy,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a history of a right mastectomy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with patients that have a history of a right mastectomy. This is a grouping of SNOMED CT and ICD-10-CM codes.),(Exclusion Criteria: Excludes codes that indicate a left or bilateral mastectomy or are unspecified.)"
2.16.840.1.113883.3.117.1.7.1.223,Subcutaneous route,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the route by which a medication is administered, in this case a subcutaneous route.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify the route by which a medication is administered, in this case a subcutaneous route. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying a subcutaneous route for giving a medication. These are SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.106.12.1004,Substance Abuse,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent substance abuse.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute Principal Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes that identify substance abuse. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.600.559,Suicide Risk Assessment,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent suicide risk assessments and the Beck depression inventory.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment or Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with suicide risk assessment and the Beck depression inventory.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.112.12.1002,Syphilis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a syphilis diagnosis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients with syphilis. This is a grouping of ICD-10-CM, ICD-9-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1009,System Reason,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent system-specific reasons for when a patient does not receive a therapy or service.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute.),(Inclusion Criteria: Includes only relevant concepts associated with system-specific reasons for not receiving a therapy or service.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1031,Telehealth Services,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent telehealth services.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying telehealth services, including telephone and online evaluation and management services.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.101.12.1082,Telephone Evaluation,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent telephone evaluations.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying evaluation and management services to a patient by telephone. This is a grouping of CPT codes.),(Exclusion Criteria: Excludes telephone evaluation and management services that last for less than five minutes.)"
2.16.840.1.113883.3.464.1003.101.12.1053,Telephone Management,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent telephone management.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant codes used to identify assessment and management services to a patient by telephone. This is a grouping of CPT codes.),(Exclusion Criteria: Excludes telephone assessment and management services that last for less than five minutes.)"
2.16.840.1.113883.3.464.1003.118.12.1081,Ten-year probability of all major osteoporosis related fracture,eCQM Update 2018-09-17,SNOMEDCT,2017-09,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a ten-year probability of all major osteoporosis-related fracture as determined by the Fracture Risk Assessment Tool (FRAX).),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying ten-year probability of all major osteoporosis-related fracture as determined by the FRAX. This is a grouping of a SNOMED CT code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.226,Thrombolytic (t-PA) Therapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medications that are prescribed for thrombolytic (t-PA) therapy for treatment of ischemic stroke.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are administered appropriate thrombolytic (t-PA) therapy for stroke.),(Inclusion Criteria: Includes only relevant concepts associated with RxNorm thrombolytic medications appropriate for stroke treatment consistent with administration by intravenous (IV) route.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1045.28,Time of Delivery,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent the time of delivery.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment. The intent of this data element is to identify the time of delivery.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify time of delivery.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1189,Tobacco Non-User,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent tobacco non-user status.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Result. ),(Inclusion Criteria: Includes only relevant concepts associated with indicating a patient does not use tobacco products, including smoking and smoke-less tobacco products such as chew, snuff, pipe, cigarette, cigar, etc.),(Exclusion Criteria: Excludes concepts that may indicate a current tobacco user status.)"
2.16.840.1.113883.3.526.3.509,Tobacco Use Cessation Counseling,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent various tobacco cessation counseling interventions.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention.),(Inclusion Criteria: Includes only relevant concepts associated with various cessation interventions which may include referral to tobacco-related services or providers, education about the benefits of stopping tobacco use, education about the negative side effects of using tobacco, and monitoring for tobacco cessation.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1190,Tobacco Use Cessation Pharmacotherapy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent medications that may be used to assist patients in decreasing or quitting tobacco use.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; bupropion hydrochloride, nicotine products (e.g., chewing gum, nasal spray, etc.), nortriptyline, and topiramate.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)"
2.16.840.1.113883.3.526.3.1278,Tobacco Use Screening,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent screening for tobacco use.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Assessment.),(Inclusion Criteria: Includes only relevant concepts associated with screening tools or questions used to obtain a patient's tobacco use status.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1170,Tobacco User,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent tobacco user status.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute.),(Inclusion Criteria: Includes only relevant concepts associated with indicating a patient uses tobacco products, including smoking and smoke-less tobacco products such as chew, snuff, pipe, cigarette, cigar, etc.),(Exclusion Criteria: Excludes concepts that may indicate a current tobacco non-user status.)"
2.16.840.1.113883.3.464.1003.198.12.1019,Total Colectomy,eCQM Update 2018-09-17,CPT,2006,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent total colectomy procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with a total colectomy, as an open or laparoscopic procedure. This is a grouping of CPT, SNOMED CT and ICD-10-PCS codes.),(Exclusion Criteria: Excludes partial colectomies.)"
2.16.840.1.113762.1.4.1110.18,Transabdominal Cerclage,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent cervical cerclage procedures performed by the abdominal approach.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this value set is to identify patients who have had a transabdominal cerclage.),(Inclusion Criteria: Includes only relevant concepts associated with cervical cerclage procedures performed by the abdominal approach.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.3006,Transfer From Emergency Department (ED) Locations,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to identify transfer from emergency department (ED) locations.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category Encounter or attribute Admission Source. The intent of this data element is to identify patients transferred from emergency department (ED) locations. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify the environment hierarchy to define an emergency department.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.3013,Transfer From Inpatient,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent types of environments used to identify inpatient/acute care hospital.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category Encounter or attribute Admission Source. The intent of this data element is to identify environment types that define inpatient/acute care hospital. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify the environment hierarchy to define Inpatient/acute care hospital.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.67.1.101.950,Transfer From Outpatient,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent patients transferred from an outpatient facility.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter or attribute related to Admission Source. The intent of this data element is to identify environment types that define a transfer from an outpatient facility. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes to indicate outpatient facility environments.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1443,Traumatic Cataract,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of traumatic cataract.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of traumatic cataract, including concussion cataract.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.196.12.1334,Trihexyphenidyl,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent trihexyphenidyl medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; trihexyphenidyl only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; trihexyphenidyl in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1285,Trimipramine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent trimipramine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; trimipramine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; trimipramine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.196.12.1408,Triprolidine,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent triprolidine medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; triprolidine only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; triprolidine in combination with other medications.)"
2.16.840.1.113883.3.464.1003.103.12.1020,Type 1 Diabetes,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of type 1 diabetes mellitus and is distinguished from other types of diabetes mellitus, including gestational, drug-induced or type 2 diabetes mellitus.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with diagnosis codes for type 1 diabetes mellitus, with or without reference to complications and comorbidities. This is a grouping of ICD-9-CM, ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: Excludes all diagnosis codes associated with gestational, drug-induced and type 2 diabetes mellitus without mention of type 1 diabetes mellitus.)"
2.16.840.1.113883.3.600.2388,Underweight,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent identifying underweight patients.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who are currently underweight.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.218,Unfractionated Heparin,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent heparin formulations that could reasonably be used to treat venous thromboembolism as a continuous infusion.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive unfractionated heparin as an intravenous infusion.),(Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used for continuous infusion of heparin and achieve therapeutic levels.),(Exclusion Criteria: Excludes concentrations < 250 UNT/ML (except those representing premixed heparin infusion bags, per inclusion criteria).)"
2.16.840.1.113883.3.464.1003.113.12.1059,"Unilateral Amputation Below or Above Knee, Unspecified Laterality",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a unilateral amputation procedure, above or below the knee, without a specified laterality.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying unilateral amputation above or below the knee without a specified laterality.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.103.12.1022,"Unilateral Amputation Procedure Below or Above Knee, Unspecified Laterality",eCQM Update 2018-09-17,SNOMEDCT,2016-09,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent unilateral amputation procedure, above or below the knee, where the laterality is unspecified.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients who have had a unilateral amputation procedure above or below the knee where the laterality is unspecified.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1020,Unilateral Mastectomy,eCQM Update 2018-09-17,CPT,2006,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent a unilateral mastectomy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with identifying that a unilateral mastectomy was performed. This is a grouping of SNOMED CT and ICD-10-CM codes.),(Exclusion Criteria: Excludes codes that indicate a bilateral mastectomy.)"
2.16.840.1.113883.3.464.1003.198.12.1071,"Unilateral Mastectomy, Unspecified Laterality",eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a unilateral mastectomy where the side was not specified.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a unilateral mastectomy performed, but the side was not specified. This is a grouping of SNOMED CT and ICD-10-CM codes.),(Exclusion Criteria: Excludes codes that indicate a bilateral mastectomy or a unilateral mastectomy where the side is specified.)"
2.16.840.1.113883.3.464.1003.102.12.1022,Upper Respiratory Infection,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent patients who have been diagnosed with an acute upper respiratory infection.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. ),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of acute upper respiratory infections. This is a value set grouping the contains ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.109.12.1024,Urine Protein Tests,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent urine protein tests.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying urine protein tests, including those that look for albumin, microalbumin, and protein.),(Exclusion Criteria: Excludes codes that identify urine protein tests that would be taken from a fetus.)"
2.16.840.1.113883.3.117.1.7.1.272,Urological Surgery,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set grouping contains concepts that represent urologic surgery procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify patients who have a urologic surgery procedure.),(Inclusion Criteria: Includes only relevant concepts associated with representing urologic surgery procedures.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1442,Use of Systemic Sympathetic alpha-1a Antagonist Medication for Treatment of Prostatic Hypertrophy,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent systemic sympathetic alpha-1a antagonist medications for treatment of prostatic hypertrophy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; oral administrations of alfuzosin hydrochloride, doxazosin, prazosin, and terazosin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)"
2.16.840.1.113762.1.4.1110.24,Uterine Horn,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent excision of the uterine horn procedures performed.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this value set is to identify patients who have had an excision of the uterine horn procedure.),(Inclusion Criteria: Includes only relevant concepts associated with excision of the uterine horn procedures by any approach.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113762.1.4.1110.16,Uterine Rupture,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent diagnoses that represent a uterine rupture.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure. The intent of this data element is to identify a uterine rupture.),(Inclusion Criteria: Includes only relevant concepts associated with identifying a uterine rupture.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.137,Uterine Window,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent diagnoses that represent a uterine window.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis. The intent of this data element is to identify a uterine window.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes that identify a uterine window.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1444,Uveitis,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of uveitis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of uveitis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.464.1003.118.12.1225,VR 36 Mental Component Summary (MCS) Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Veterans RAND 36 Item Health Survey (VR-36) Mental Component Summary (MCS) Score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with codes to identify the Veterans RAND 36 Item Health Survey (VR-36) Mental Component Summary (MCS) Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1226,VR 36 Physical Component Summary (PCS) Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Veterans RAND 36 Item Health Survey (VR-36) Physical Component Summary (PCS) Score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Veterans RAND 36 Item Health Survey (VR-36) Physical Component Summary (PCS) Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1177,VR12 Mental Component T Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Veterans RAND 12 Item Health Survey (VR-12) Mental Component Summary (MCS) T-Score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Veterans RAND 12 Item Health Survey (VR-12) Mental Component Summary (MCS) T-Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.118.12.1176,VR12 Physical Component T Score,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent the Veterans RAND 12 Item Health Survey (VR-12) Physical Component Summary (PCS) T-Score.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Assessment, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with the Veterans RAND 12 Item Health Survey (VR-12) Physical Component Summary (PCS) T-Score. This is a grouping of LOINC codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1039,Varicella Zoster,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent varicella zoster (i.e., chickenpox and shingles) infections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with all varicella zoster infections. This is a grouping of ICD-10-CM and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1067,Varicella Zoster Antibody Test (IgG Antibody Presence),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests measuring the presence of IgG antibody to varicella zoster in serum, cerebrospinal fluid (CSF), and body fluids.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with tests measuring the presence of IgG antibody to varicella zoster in serum, CSF and body fluids.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1066,Varicella Zoster Antibody Test (IgG Antibody Titer),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent laboratory tests measuring the titre of IgG antibody to varicella zoster in serum and cerebrospinal fluid (CSF).),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Laboratory Test, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with tests measuring the titre or amount of IgG antibody to varicella zoster in serum or CSF.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.196.12.1170,Varicella Zoster Vaccine (VZV),eCQM Update 2018-09-17,CVX,2018-07,2.16.840.1.113883.12.292,"(Clinical Focus: This value set contains concepts that represent varicella zoster vaccines.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Immunization, Administered.),(Inclusion Criteria: Includes only relevant concepts associated with all relevant varicella zoster vaccine codes. This is a grouping of CVX codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.110.12.1040,Varicella Zoster Vaccine (VZV) Administered,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedure codes for varicella zoster vaccine administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all varicella zoster vaccine administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.109.12.1011,Vascular Access for Dialysis,eCQM Update 2018-09-17,CPT,2016,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent procedures related to accessing the vascular system for dialysis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with procedures related to accessing the vascular system for dialysis such as inserting a needle or catheter or creating a shunt. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1445,Vascular Disorders of Iris and Ciliary Body,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of vascular disorders of iris and ciliary body.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of a vascular disorder or the iris and/or ciliary body, including rubeosis iridis.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.117.1.7.1.279,Venous Thromboembolism,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a venous thromboembolism, including a pulmonary embolism.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category or attribute related to Diagnosis. The intent of this data element is to identify patients who have a venous thromboembolism, including those who have a pulmonary embolism. ),(Inclusion Criteria: Includes only relevant concepts associated with codes representing pulmonary embolism and proximal venous thromboembolisms, including specific proximal veins: popliteal vein, femoral/superficial femoral vein, deep femoral vein, ileofemoral vein, iliac vein and inferior vena cava.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.230,Venous foot pumps (VFP),eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent a venous foot pump device applied for venous thromboembolism (VTE) prophylaxis. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Device. The intent of this data element is to identify patients who have a venous foot pump device applied for VTE prophylaxis. ),(Inclusion Criteria: Includes only relevant concepts associated with codes which represent venous foot pump devices which are used for VTE prophylaxis.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.666.5.3015,Ventricular Assist Device placement,eCQM Update 2018-09-17,ICD10PCS,2019,2.16.840.1.113883.6.4,"(Clinical Focus: This value set contains concepts that represent procedures used to identify the placement of a ventricular assist device.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Performed. The intent of this data element is to identify procedures for ventricular assist device placement. ),(Inclusion Criteria: Includes only relevant concepts associated with identifying patients with ventricular assist device placement. This is a grouping of ICD-10-PCS and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1483,Visual Acuity 20/40 or Better,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent visual acuity findings that are 20/40 or better.),(Data Element Scope: This value set may use the Quality Data Model (QDM) attribute related to Result. ),(Inclusion Criteria: Includes only relevant concepts associated with distance vision findings of 20/40 or better.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.526.3.1446,Visual Field Defects,eCQM Update 2018-09-17,ICD10CM,2019,2.16.840.1.113883.6.90,"(Clinical Focus: This value set contains concepts that represent a diagnosis of visual field defects.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnosis.),(Inclusion Criteria: Includes only relevant concepts associated with a diagnosis of visual field defects, including scotoma and decreased field of vision.),(Exclusion Criteria: Excludes concepts that pertain to 'unspecified eye.')"
2.16.840.1.113883.3.526.3.1447,Vitreous Procedures,eCQM Update 2018-09-17,CPT,2018,2.16.840.1.113883.6.12,"(Clinical Focus: This value set contains concepts that represent vitreous procedures.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Procedure.),(Inclusion Criteria: Includes only relevant concepts associated with vitreous procedures, including vitrectomy, aspiration or injection of vitreous.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.232,Warfarin,eCQM Update 2018-09-17,RXNORM,2018-07,2.16.840.1.113883.6.88,"(Clinical Focus: This value set contains concepts that represent warfarin medications that are administered to patients to reduce the risk of blood clot formation.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction.),(Inclusion Criteria: Includes only relevant concepts associated with drug forms that are consistent with oral administration, such as tablets. Only single ingredient.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.381,Warning Signs and Symptoms Education,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent procedures used to represent patients who receive education for stroke warning signs and symptoms.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication. The intent of this data element is to identify patients who receive education on stroke warnings signs and symptoms. ),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing education on warning signs and symptoms.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.121.12.1015,Weight,eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent that a patient's weight has been measured.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Physical Exam, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with identifying a patient's weight has been measured. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes codes for patient's ideal body weight, estimated body weight and measured/calculated body fat.)"
2.16.840.1.113883.3.600.1510,Weight Reduction Recommended,eCQM Update 2018-09-17,HCPCS,2018,2.16.840.1.113883.6.285,"(Clinical Focus: This value set contains concepts that represent management and maintenance of weight.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Intervention or Procedure. ),(Inclusion Criteria: Includes only relevant concepts associated with interventions addressing healthy eating, goal setting, weight management and maintenance.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.123.12.1007,White,eCQM Update 2018-09-17,CDCREC,1.2,2.16.840.1.113883.6.238,"(Clinical Focus: This value set contains concepts that represent a patient's race as white.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Race.),(Inclusion Criteria: Includes only relevant concepts associated with a code to identify a patient's race as white. This is a grouping of a CDCREC code.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.117.1.7.1.415,Written Information Given,eCQM Update 2018-09-17,SNOMEDCT,2018-03,2.16.840.1.113883.6.96,"(Clinical Focus: This value set contains concepts that represent qualifiers used to represent patients who receive written information.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Communication. The intent of this data element is to identify patients who receive written information.),(Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing written information given.),(Exclusion Criteria: No exclusions.)"
2.16.840.1.113883.3.464.1003.198.12.1034,X-Ray Study (all inclusive),eCQM Update 2018-09-17,LOINC,2.64,2.16.840.1.113883.6.1,"(Clinical Focus: This value set contains concepts that represent any radiology study involving x-rays.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Diagnostic Study.),(Inclusion Criteria: Includes only relevant concepts associated with tests such as computerized tomography, x-ray, magnetic resonance imaging or radiofrequency testing. This is a grouping of LOINC codes.),(Exclusion Criteria: Excludes codes that indicate that this test was ordered only, and not necessarily performed.)"